Encapsulated islets for diabetes therapy: History, current progress, and critical issues requiring solution

Advanced Drug Delivery Reviews

Volumn 67-68, Issue , 2014, Pages 35-73

  Scharp, David W ^a   Marchetti, Piero ^b  

^a Scharp Lacy Research Institute   (United States)

^b CISANELLO HOSPITAL   (Italy)

Author keywords

"Conformal coating"; "Minimum volume capsule"; Diabetes; Encapsulation; Immuno isolation; Implantation; Islets; Macro device; Micro device; Transplantation

Indexed keywords

ANIMALS; ION IMPLANTATION; MEDICAL PROBLEMS; TRANSPLANTATION (SURGICAL);

CONFORMAL COATINGS; IMMUNO-ISOLATION; ISLETS; MACRO-DEVICE; MICRO-DEVICE; MINIMUM VOLUMES;

ENCAPSULATION;

INSULIN;

ANIMAL; DEVICES; DIABETES MELLITUS; HUMAN; PANCREAS ISLET TRANSPLANTATION; PANCREAS TRANSPLANTATION; PROCEDURES; SECRETION (PROCESS); XENOGRAFT;

ANIMALS; DIABETES MELLITUS; HUMANS; INSULIN; ISLETS OF LANGERHANS TRANSPLANTATION; PANCREAS TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS;

EID: 84898545288     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2013.07.018     Document Type: Review

References (489)

1. Downing R. Studies on the Isolation and Transplantation of the Islets of Langerhans 1983, 1-358. (Thesis for Degree of Doctor of Medicine), University of Birmingham, Worcester Royal Infirmary, United Kingdom.
2. Downing R. Historical review of pancreatic islet transplantation. World J. Surg. 1984, 8:137-142.
3. Papaspyros N.S. The History of Diabetes Mellitus 1964, George Thieme Verlag, Stuttgart.
4. Gemmill C.L. The Greek concept of diabetes. Bull. N. Y. Acad. Med. 1972, 48:1033-1036.
5. King L.S. Empiricism, rationalism, and diabetes. JAMA 1964, 187:521-527.
6. Gwei-djen L., Needham J. Records of diseases in ancient China. Diseases in Antiquity 1967, 222-237. Charles C. Thomas, Springfield. D. Brothwell, A.T. Sandison (Eds.).
7. Rolleston H. The endocrine disorders. A Short History of Some Common Diseases 1934, 87-100. Oxford University Press, New York. W.R. Bett (Ed.).
8. Barach J.H. Diabetes and Its Treatment 1949, Oxford University Press, New York.
9. Major R.M. Classic Description of Disease 1932, Charles C Thomas, Springfield. second ed.
10. Garrison F.H. Historical aspects of diabetes and insulin. Bull. N. Y. Acad. Med. 1925, 1:127-133.
11. Levine R. History of etiology of diabetes mellitus. Arch. Pathol. 1964, 78:405-408.
12. Cawley T. A fingular café of diabetes, confifting entirely in the quality of the urine; with an inquiry into the different theories of that difeafe. Lond. Med. J. 1788, 9:286-308.
13. Bouchardat A. De la glycosurie ou diabète sucré, Balliere, Paris 1875.
14. Lancereaux M. Notes et réflexions à propos de deux cas de diabète sucré avec altération du pancréas. B. Acad. Nat. Med. Paris 1877, 6:1215-1240.
15. Langerhans P. "Contributions to the microscopic anatomy of the pancreas" Berlin Pathologic Institute, 1869. J. R. Soc. Med. 1988, 81. A. Sakula (Ed.).
16. Schafer E.A. Address in physiology on internal secretions. Lancet 1895, 2:321-324.
17. Opie E.L. Diabetes mellitus associated with hyaline degeneration of the islands of Langerhans of the pancreas. J. H. H. Bull. 1901, 12:263-264.
18. Mann R.J. Historical vignette; "Honey urine" to pancreatic diabetes: 600B.C.-1922. Mayo Clin. Proc. 1971, 46:56-58.
19. Mering J.V., Minkowski O. Diabetes mellitus nach pankreasexstirpation. Arch. Exp. Pathol. Pharmakol. 1889, 26:371-387.
20. Laguesse E. Preuve expérimentale du balancement dans les ilots endocrines du pancréas. J. Physiol. Pathol. Gen. 1911, 13:5-18.
21. Banting F.G., Best C.H. The internal secretion of the pancreas. J. Lab. Clin. Med. 1922, 7:251-266.
22. Banting F.G., Best C.H. Pancreatic extracts in the treatment of diabetes mellitus. Can. Med. Assoc. J. 1922, 12:141-146.
23. Bliss M. The Discovery of Insulin 2007, The University of Chicago Press, Chicago, 60637.
24. Fitz R.H., Joslin E.P. Diabetes mellitus at the Massachusetts General Hospital from 1824 to 1898. A study of the medical records. JAMA 1898, 31:165-171.
25. Joslin E.P. The Treatment of Diabetes Mellitus, With Observations Upon 1300 Cases 1917, Lea and Febiger, Philadelphia.
26. Williams P.W. Notes on diabetes treated with extract and by grafts of a sheep's pancreas. BMJ 1984, 2:1303-1304.
27. Ssobolew L.W. Zur normalen und pathologischen morphologie der inneren secretion der bauchspeicheldrüse. Virchows Arch. Pathol. Anat. Physiol. 1902, 168:91-128.
28. Pybus F.C. Notes on suprarenal and pancreatic grafting. Lancet 1924, 2:550-551.
29. Fischera G. Impianti omoplastici feto-umani nel cancro e nel diabete. Tumori 1928, 14:434-477.
30. Minkowski O. Untersuchungen über den diabetes mellitus nach exstirpation des pankreas. Arch. Exp. Pathol. Pharmakol. 1893, 31:85-189.
31. Thiroloix J. Des effets de la section des nerfs du foie chez les animaux normaux ou rendus diabétiques par l'extirpation du pancreas. C. R. Soc. Biol. 1895, 67:256-261.
32. Lombroso U. Die gewebselemente, welche die innere funktion des pankreas besorgen. Ergeb. Physiol. 1910, 9:11-89.
33. Pratt J.H., Murphy F.T. Pancreatic transplantation in the spleen. JEM 1913, 17:252-272.
34. Brancati R. Innesti sperimentali di pancreas. Arch. Atti Soc. Ital. Chir. 1929, 35:951-959.
35. Allen F.M. Experimental studies in diabetes. Series III. The pathology of diabetes. 3. Nervous influences in the etiology of experimental diabetes. J. Metab. Res. 1922, 1:53-73.
36. Rundles W.R., Swan H. Islet cell transplantation. Surg. Forum 1957, 7:502-506.
37. Murrell L.R. Mammalian pancreatic islet tissue in organ culture. I. Methods of culture and in vitro histogenesis. Exp. Cell Res. 1966, 41:350-364.
38. Murrell L.R., Morgan C.R., Lazarow A. Mammalian pancreatic islet tissue in organ culture. II. Insulin contents of tissues and culture medium. Exp. Cell Res. 1966, 41:365-375.
39. Hegre O.D., McEvoy R.C., Bachelder V., Lazarow A. Fetal rat pancreas. Differentiation of the islet cell component in vivo and in vitro. Diabetes 1973, 22:577-583.
40. Hegre O.D., Wells L.J., Lazarow A. Response of beta cells to different levels of glucose. Fetal pancreas grown in organ culture and subsequently transplanted to maternal hosts. Diabetes 1970, 19:906-915.
41. McEvoy R.C., Hegre O.D. Syngeneic transplantation of fetal rat pancreas. III. Effect of insulin treatment on the growth and differentiation of pancreatic implants. Diabetes 1979, 28:141-146.
42. Hegre O.D., Leonard R.J., Rusin J.D., Lazarow A. Transplantation of the fetal rat pancreas: quantitative morphological analysis of islet tissue growth. Anat. Rec. 1976, 185:209-222.
43. Hegre O.D., Leonard R.J., Erlandsen S.L., McEvoy R.C., Parsons J.A., Elde R.P., Lazarow A. Transplantation of islet tissue in the rat. Acta Endocrinol. Suppl. 1976, 205:257-258.
44. Browning H., Resnik P. Homologous and heterologous transplantation of pancreatic tissue in normal and diabetic mice. Yale J. Biol. Med. 1951, 24:141-152.
45. Coupland R.E. The survival and growth of pancreatic tissue in the anterior chamber of the eye of the albino rat. J. Endocrinol. 1960, 20:69-77.
46. Dubois A.M., Gonet A. Effets de la greffe de pancréas foetal sur glycémie et la regeneration des îlots de Langerhans de rats alloxanises ou pancreatectomisés. Acta Anat. 1960, 41:336.
47. Gonet A.E., Renold A.E. Homografting of fetal rat pancreas. Diabetologia 1965, 1:91-96.
48. House E.L., Burton C., Cooper H., Anderson E. The implantation of neo-natal pancreas into the cheek pouch of the alloxan diabetic hamster. Endocrinology 1958, 63:389-391.
49. House E.L., Jacobs M.S., Pansky B. Homoplastic transplantation of pancreas in diabetic hamsters. Transplant. Bull. 1961, 28:435-441.
50. Younoszai R., Sorenson R.L., Lindall A.W. Homotransplantation of isolated pancreatic islets. Diabetes 1970, 19(Suppl. 1):406.
51. Reemtsma K. Experimental islet cell grafting: a transplantation model. Transplant. Proc. 1970, 2:513-515.
52. Hellerstrom C. A method for the microdissection of intact pancreatic islets of mammals. Acta Endocrinol. 1964, 45:122-322.
53. Moskalewski S. Isolation and culture of the islets of Langerhans of the guinea pig. Gen. Comp. Endocrinol. 1965, 5:342-353.
54. Lacy P.E., Kostianovsky M. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 1967, 16:35-39.
55. Sorenson R.L. Isolation of an insulin secretion granule rich fraction from rat islets. Anat. Rec. 1968, 160:498.
56. Scharp D.W., Kemp C.B., Knight M.J., Ballinger W.F., Lacy P.E. The use of Ficoll in the preparation of viable islets of Langerhans from the rat pancreas. Transplantation 1973, 16:686-689.
57. Ballinger W.F., Lacy P.E. Transplantation of intact pancreatic islets in rats. Surgery 1972, 72:175-186.
58. Naji A., Reckard C.R., Ziegler M.M., Barker C.F. Physiologic and immunologic status of long-functioning transplanted pancreatic islets in rats. Surg. Forum 1974, 25:374-376.
59. Kemp C.B., Knight M.J., Scharp W.F., Ballinger W.F., Lacy P.E. Effects of transplantation site on the results of pancreatic islet isografts in diabetic rats. Diabetologia 1973, 9:486-491.
60. Scharp D.W., Lacy P.E., Santiago J.V., McCullough C.S., Weide L.G., Falqui L., Marchetti P., Gingerich R.L., Jaffe A.S., Cryer P.E., Anderson C.B., Flyle M.W. Insulin independence after islet transplantation into type 1 diabetic patient. Diabetes 1990, 39:515-518.
61. Scharp D.W., Lacy P.E., Santiago J.V., McCullough C.S., Weide L.G., Boyle P.J., Falqui L., Marchetti P., Ricordi C., Gingerich R.L., Jaffe A.S., Cryer P.E., Hanto D.W., Anderson C.B., Flye M.W. Results of our first nine intraportal islets allografts in type 1, insulin dependent diabetic patients. Transplantation 1991, 51:76-85.
62. Lacy P.E. Experimental immune-alteration. World J. Surg. 1984, 8:198-203.
63. Lacy P.E. Gordon Wilson Lecture, the prevention of immune rejection of islet transplants without the use of immunosuppressive drugs. Trans. Am. Clin. Climatol. Assoc. 1984, 95:68-78.
64. Lacy P.E., Davie J.M., Finke E.H., Scharp D.W. Prolongation of islet allograft survival. Transplantation 1979, 27:171-174.
65. Scharp D.W., Norbert S.M., Sparks R.E. Islet immuno-isolation: the use of hybrid artificial organs to prevent islet tissue rejection. World J. Surg. 1984, 8:221-229.
66. Scharp D.W. 7. Encapsulated human islet allografts; providing safety with efficacy. Cellular Transplantation: From Laboratory to Clinic 2007, 135-153. Academic Press, Massachusetts. C.R. Halberstadt, D.F. Emerich (Eds.).
67. Calafiore R., Basta G., Lemmi A., Montanucci M.P., Calabrese G., Racanicchi L., Manusco F., Brunetti P. Microencapsulated pancreatic islet allografts into non-immunosuppressed patients with type 1 diabetes. Diabetes Care 2011, 34:2406-2409.
68. Shiroki R., Mohanakumar T., Scharp D.W. Analysis of the serological and cellular sensitization induced by encapsulated human islets transplantation in type I and type II diabetes patients. Cell Transplant. 1995, 4:535-538.
69. Centers for Disease Control and Prevention National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States 2011 2011, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA.
70. Global Guidelines for Type 2 Diabetes, Clinical Guidelines Task Force, International Diabetes Foundation 2012.
71. Bisceglie V.V. Über die antineoplastiche Immunität. E. Krebsforsch. 1933, 40:141.
72. Algire G.H., Legallais F.Y. Recent developments in the transparent chamber technique as adapted to the mouse. J. Natl. Cancer Inst. 1949, 10:225.
73. Algire G.H. Visualizing cellular behavior in vivo. J. Int. Chir. 1953, 13:381-384.
74. Algire G.H., Weaver J.M., Prehn R.T. Growth of cells in vivo in diffusion chambers. I. Survival of homografts in immunized mice. J. Natl. Cancer Inst. 1954, 15:493.
75. Prehn R.T., Weaver J.M., Algire G.H. The diffusion-chamber technique applied to a study of the nature of homograft resistance. J. Natl. Cancer Inst. 1954, 15:509.
76. Weaver J.M., Algire G.H., Prehn R.T. The growth of cells in vivo in diffusion chambers. II. The role of cells in the destruction of homografts in mice. J. Natl. Cancer Inst. 1955, 15:1737.
77. Algire G.H., Weaver J.M., Prehn R.T. Studies on tissue homotransplantation in mice, using diffusion-chamber methods. Ann. N. Y. Acad. Sci. 1957, 64:1009-1013.
78. Algire G.H. Summary of studies of transplantation of homologous tissues. Fed. Proc. 1957, 16:601-602.
79. Algire G.H. Diffusion-chamber techniques for studies on cellular immunity. Ann. N. Y. Acad. Sci. 1957, 69:663.
80. Algire G.H., Borders M.L., Evans V.J. Studies of heterografts in diffusion chambers in mice. J. Natl. Cancer Inst. 1958, 20:1187-1201.
81. Algire G.H. Growth inhibition of homografts of a plasma-cell neoplasm in cell-impenetrable diffusion chambers placed in hyperimmunized mice. J. Natl. Cancer Inst. 1959, 23:435-439.
82. de Vos P., Spasojevic M., Faas M.M. Treatment of diabetes with encapsulated islets. Therapeutic Applications of Cell Microencapsulation 2010, 38-53. Landes Bioscience and Springer Science+Business Media, New York. J.L. Pedraz, G. Orive (Eds.).
83. Strautz R.L. Studies of hereditary-obese mice (Ob/Ob) after implantation of pancreatic islets in Millipore filter capsules. Diabetologia 1970, 6:306.
84. Gates R.J., Lazarus N.R. Reversal of streptozotocin-induced diabetes by intraperitoneal implantation of encapsulated neonatal rabbit pancreatic tissue. Lancet 1977, 1:971.
85. Weber C., Weil R., McIntosh R., Hogly H., Warden G., Reemtsma K. Xenotransplantation of porcine islets into hyperglycemic rats. Surgery 1975, 77:208.
86. Valente V., Feno M., Campisi C., Parodi F., Tosatti E. Allogeneic pancreatic islet transplantation by means of artificial membrane chambers in 13 diabetic patients. Transplant. Proc. 1980, 12:223.
87. Klomp G.F., Hashiguchi H., Dobelle W.H., Ronel S., D'Andrea M. Hybrid artificial pancreas with hydrogel membranes. Artif. Organs 1981, 5A:38.
88. Swenne I., Reibruing L., Petersson B., Andersson A. Growth of pancreatic islets of normal mice after transplantation into obese hyperglycemic littermates. Acta Endocrinol. Suppl. 1979, 227:70.
89. Helmke K., Slijepcevic M., Federlin K. Wirkung einer transplantation isolierter homologer Langerhans scher inseln auf der experimentellen diabetes der ratte kongr. D. Diab. Munchen 1973, 8:35.
90. Garvey J.F.W., Morris P.J., Finch D.R.A. Experimental pancreas transplantation. Lancet 1979, 1:971.
91. Theodorou N.A., Vrbova H., Tyhurst M., Howell S.L. Problems in the use of polycarbonate diffusion chambers for syngeneic pancreatic islet transplantation in rats. Diabetologia 1980, 18:313.
92. Buschard K. Cultivation of islets of Langerhans in Millipore chamber in vivo. Horm. Metab. Res. 1975, 7:441.
93. Andersson A. Survival of pancreatic islet allografts. Lancet 1979, 2:585.
94. Theodorou N.A., Howell S.L. An assessment of diffusion chambers for use in pancreatic islet transplantation. Transplantation 1979, 27:350.
95. Helmke K., Freiltog F., Schneider R., Laube H., Badenhop T., Federlin K. Islet cell transplantation in diabetic rats using diffusion chambers. Islet-Pancreas-Transportation and Artificial Pancreas, Thieme-Stratton, New York 1982, 45-48. F. Federlin, E. Pfeiffer, S. Raptis (Eds.).
96. Jolley W.B., Hinshaw D.B., Call T.W., Alverel L.S. Xenogeneic pancreatic islet transplantation in proteolytic enzyme bonded diffusion chambers in diabetic rats. Transplant. Proc. 1977, 9:363.
97. Chen Y., Mason N.S., Scharp D.W., Ballinger W.F., Sparks R.E. Collagenase immobilized on Millipore membranes. Advances in Chemistry Series no. 199 1982, 483-491. American Chemical Society. S.L. Cooper, N.A. Peppas (Eds.).
98. Knazek R.A., Gullino P.M., Kohler P.O., Dedrick R.L. Cell culture on artificial capillaries: an approach to tissue growth in vitro. Science 1972, 178:65.
99. Chick W.L., Like A.A., Lauris V. Beta cell culture on synthetic capillaries: an artificial endocrine pancreas. Science 1975, 187:847.
100. Lanza R.P., Borland K.M., Lodge P., Carretta M., Sullivan S.J., Muller T.E., Solomon B.A., Maki T., Monaco A.P., Chick W.L. Pancreatic islet transplantation using membrane diffusion chambers. Transplant. Proc. 1992, 24:2935-2936.
101. Lanza R.P., Beyer A.M., Staruk J.E., Chick W.L. Biohybrid artificial pancreas. Long-term function of discordant islet xenografts in streptozotocin diabetic rats. Transplantation 1993, 56:1067-1072.
102. Lanza R.P., Borland K.M., Lodge P., Carretta M., Sullivan S.J., Muller T.E., Solomon B.A., Maki T., Monaco A.P., Chick W.L. Treatment of severely diabetic pancreatectomized dogs using a diffusion-based hybrid pancreas. Diabetes 1992, 41:886-889.
103. Lanza R.P., Borland K.M., Staruk J.E., Appel M.C., Solomon B.A., Chick W.L. Transplantation of encapsulated canine islets into spontaneously diabetic BB/Wor rats without immunosuppression. Endocrinology 1992, 131:637-642.
104. Lanza R.P., Ecker, D.M., Ringeling, J., Marsh, J.P., Chick, W.L. Devices containing cells or tissue and an agent that inhibits damage by a host cell molecule. United States Patent 6,287,558, September 11, 2001.
105. Lanza R.P., Butler D.H., Borland K.M., Harvey J.M., Faustman D.L., Solomon B.A., Muller T.E., Rupp R.G., Maki T., Monaco A.P., Chick W.L. Successful xenotransplantation of a diffusion-based biohybrid artificial pancreas: a study using canine, bovine and porcine islets. Transplant. Proc. 1992, 24:669-671.
106. Lanza R.P., Butler D.H., Borland K.M., Staruk J.E., Faustman D.L., Solomon B.A., Muller T.E., Rupp R.G., Maki T., Monaco A.P. Xenotransplantation of canine, bovine, and porcine islets in diabetic rats without immunosuppression. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:11100-11104.
107. Lanza R.P., Sullivan S.J., Chick W.L. Islet transplantation with immunoisolation. Diabetes 1992, 41:1503-1510.
108. Dionne K.E., Cain B.M., Li R.H., Bell W.J., Doherty E.J., Rein D.H., Lysaght M.J., Gentile F.T. Transport characterization of membranes for immunoisolation. Biomaterials 1996, 17:257-266.
109. Lacy P.E., Hegre O.D., Gerasimidi-Vazeou A., Gentile F.T., Dionne K.E. Maintenance of normoglycemia in diabetic mice by subcutaneous xenografts of encapsulated islets. Science 1991, 254:1782-1784.
110. Kartsen V., Tritschler S., Mandes K., Belcourt A., Pinget M., Kessler L. Chemotaxis activation of peritoneal murine macrophages induced by the transplantation of free and encapsulated pancreatic rat islets. Cell Transplant. 2000, 9:39-43.
111. Kessler L., Legeay G., West R., Belcourt A., Pinget M. Physicochemical and biological studies of corona-treated artificial membranes used for pancreatic islets encapsulation: mechanism of diffusion and interface modification. J. Biomed. Mater. Res. 1997, 34:235-245.
112. Kessler L., Pinget M., Aprahamian M., Dejardin P., Damge C. In vivo and in vivo studies of the properties of an artificial membrane for pancreatic islet encapsulation. Horm. Metab. Res. 1991, 23:312-317.
113. Scharp D.W., Swanson C.J., Olack B.J., Latta P.P., Hegre O.D., Doherty E.J., Gentile F.T., Flavin K.S., Ansara M.F., Lacy P.E. Protection of encapsulated human islets implanted without immunosuppression in patients with type I or type II diabetes and in nondiabetic control subjects. Diabetes 1994, 43:1167-1170.
114. Mohanakumar T., Narayanan K., Desai N., Ramachandran S., Shenoy S., Jendrisak M., Susskind B.M., Olack B., Benshoff N., Phelan D.L., Brennan D.C., Fernandez L.A., Odorico J.S., Polonsky K.S. A significant role for histocompatibility in human islet transplantation. Transplantation 2006, 82:180-187.
115. Brauker J., Frost G.H., Dwarki V., Nijjar T., Chin R., Carr-Brendel V., Jasunas C., Hodgett D., Stone W., Cohen L.K., Johnson R.C. Sustained expression of high levels of human factor IX from humans cells implanted within an immunoisolation device into athymic rodents. Hum. Gene Ther. 1998, 9:879-888.
116. Brauker J., Martinson L.A., Young S.K., Johnson R.C. Local inflammatory response around diffusion chambers containing xenografts: nonspecific destruction of tissues and decreased local vascularization. Transplantation 1996, 61:1671-1677.
117. Brauker J.H., Carr-Brendel V.E., Martinson L.A., Crudele J., Johnston W.D., Johnson R.C. Neovascularization of synthetic membranes directed by membrane microarchitecture. J. Biomed. Mater. Res. 1995, 29:1517-1524.
118. Josephs S.F., Loudovaris T., Dixit A., Young S.K., Johnson R.C. In vivo delivery of recombinant human growth hormone from genetically engineered human fibroblasts implanted within Baxter immunoisolation devices. J. Mol. Med. 1999, 77:211-214.
119. McKenzie A.W., Georgiou H.M., Zhan Y., Brady J.L., Lew A.M. Protection of xenografts by a combination of immunoisolation and a single dose of anti-CD4 antibody. Cell Transplant. 2001, 10:183-193.
120. Trivedi N., Steil G.M., Colton C.K., Bonner-Weir S., Weir G.C. Improved vascularization of planar membrane diffusion devices following continuous infusion of vascular endothelial growth factor. Cell Transplant. 2000, 9:115-124.
121. Aznar J., Gomez L. Possible clinical usefulness of embryonic stem cells. Rev. Clin. Esp. 2012, 212:403-406.
122. Geron Corporation World's first clinical trial of human embryonic stem cell therapy cleared. Regen. Med. 2009, 4:161.
123. Okarma T. Interview with Thomas Okerma, MD, PhD, CEO Geron. Rejuvenation Res. 2009, 12:295-300.
124. Strauss S. Geron trial resumes but standards for stem cell trials remain elusive. Nat. Biotechnol. 2010, 28:989-990.
125. Chapman A.R., Scala C.C. Evaluating the first-in-human clinical trial of a human embryonic stem cell-based therapy. Kennedy Inst. Ethics 2012, 22:243-261.
126. Storrs R., Dorian R., King S.R., Lakey J., Rilo H. Preclinical development of the Islet Sheet. Ann. N. Y. Acad. Sci. 2001, 944:252-266.
127. Lamb M., Storrs R., Li S., Liang O., Laugenour K., Dorian R., Chapman D., Ichii H., Imagawa D., Foster C., King S., Lakey J.R. Function and vitality of human islets encapsulated in alginate sheets: in vitro and in vivo culture. Transplant. Proc. 2011, 43:3265-3266.
128. King S.R., Dorian R., Storrs R.W. Requirements for encapsulation technology and the challenges for transplantation of islets of Langerhans. Graft 2001, 4:491-499.
129. Ludwig B., Rotem A., Schmid J., Weir G.C., Colton C.K., Brendel M.D., Neufeld T., Block N.L., Yavriyants K., Steffen A., Ludwig S., Chavakis T., Reichel A., Azarov D., Zimermann B., Maimon S., Balyura M., Rozenshtein T., Shabtay N., Vardi P., Bloch K., de Vos P., Schally A.V., Bornstein S.R., Barkai U. Improvement of islet function in a bioartificial pancreas by enhanced oxygen supply and growth hormone releasing hormone agonist. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:5022-5027.
130. Ludwig B., Zimerman B., Steffen A., Yavriants K., Azarov D., Reichel A., Vardi P., German T., Shabtay N., Rotem A., Evron Y., Neufeld T., Mimon S., Ludwig S., Brendel M.D., Bornstein S.R., Barkai U. A novel device for islet transplantation providing immune protection and oxygen supply. Horm. Metab. Res. 2010, 42:918-922.
131. Barkai U., Weir G.C., Colton C.K., Ludwig B., Bornstein S.R., Brendel M.D., Neufeld T., Bremer C., Leon A., Evron Y., Yavriyants K., Azarov D., Zimermann B., Maimon S., Shabtay N., Balyura M., Rozenshtein T., Vardi P., Bloch K., de Vos P., Rotem A. Enhanced oxygen supply improves islet viability in a new bioartificial pancreas. Cell Transplant. 2013, 22:1463-1476.
132. Chick W.L., Perna J.J., Louis W., Law D., Galletti P.M., Panol G., Whittemore A.B., Like A.A., Colton C.K., Lysaght M.J. Artificial pancreas using live beta cells. Effects on glucose homeostasis in diabetic rats. Science 1977, 197:780.
133. Tze W.J., Wong F.C., Chen I.M., O'Young S. Implantable artificial endocrine pancreas unit used to restore normoglycemic in the diabetic rat. Nature 1976, 264:466.
134. Sun A.M., Parisius W., Healy G.M., Vacek L., MacMorine H.G. The use in diabetic rats and monkeys of artificial capillary units containing cultured islets of Langerhans. Diabetes 1977, 26:1136.
135. Orsetti A., Guy C., Zouai N., Deffay R. Implantation du distributeur bio-artificiel el'insuline chez le chien utilizant des îlots de langerhans d'especes animals differentes. C. R. Soc. Biol. 1978, 172:144.
136. Tze W.J., Wong F.C., Chen L.M. Implantable artificial capillary unit for pancreatic islet allograft and xenograft. Diabetologia 1979, 16:247.
137. Tze W.J., Tai J., Davis H.R. Studies with implantable artificial capillary units containing rat islets on diabetic dogs. Diabetologia 1980, 19:541.
138. Sun A., Parisius W., Macmorine H., Sefton M., Stone R. An artificial endocrine pancreas containing cultured islets on Langerhans. Artif. Organs 1980, 4:275.
139. Feldman S., Dodi G., Haid K., Scharp D.W., Ballinger W., Lacy P. Artificial hybrid pancreas. Surg. Forum 1977, 28:439.
140. Monaco A.P., Maki T., Ozato H., Carretta M., Sullivan S.J., Borland K.M., Mahoney M.D., Chick W.L., Muller T.E., Wolfrum J., Solomon B. Transplantation of islet allografts and xenografts in totally pancreatectomized diabetic dogs using the hybrid artificial pancreas. Ann. Surg. 1991, 214:339-360.
141. Sullivan S.J., Maki T., Borland K.M., Mahoney M.D., Solomon B.A., Muller T.E., Monaco A.P., Chick W.L. Biohybrid artificial pancreas: long-term implantation studies in diabetic, pancreatectomized dogs. Science 1991, 252:718-721.
142. Sullivan S.J., Maki T., Carretta M., Ozato H., Borland K., Mahoney M.D., Muller T.E., Solomon B.A., Monaco A.P., Chick W.L. Evaluation of the hybrid artificial pancreas in diabetic dogs. ASAIO J. 1992, 38:29-33.
143. Petruzzo P., Pibiri L., De Giudici M.A., Basta G., Calafiore R., Falorni A., Brunetti P., Brotzu G. Xenotransplantation of microencapsulated pancreatic islets contained in a vascular prosthesis: preliminary results. Transpl. Int. 1991, 4:200-204.
144. Calafiore R., Basta G., Falorni A., Ciabattoni P., Brotzu G., Cortesini R., Brunetti P. Intravascular transplantation of microencapsulated islets in diabetic dogs. Transplant. Proc. 1992, 24:935-936.
145. Calafiore R. Transplantation of microencapsulated pancreatic human islets for therapy of diabetes mellitus. A preliminary report. ASAIO J. 1992, 38:34-37.
146. Prochorov A.V., Tretjak S.I., Goranov V.A., Glinnik A.A., Goltsev M.V. Treatment of insulin dependent diabetes mellitus with intravascular transplantation of pancreatic islet cells without immunosuppressive therapy. Adv. Med. Sci. 2008, 53:240-244.
147. Sparks R.E., Mason N.S., Finley T.C., Scharp D.W. Development, testing and modeling of an islet transplantation chamber. Trans. ASAIO 1982, 28:229.
148. Bergen J.F., Mason N.S., Scharp D.W., Sparks R.E. Insulin inhibition of islets in transplantation chambers. Artif. Organs 1981, 5A:67.
149. Dulong J.L., Legallais C. Contributions of a finite element model for the geometric optimization of an implantable bioartificial pancreas. Artif. Organs 2002, 26:583-589.
150. Dulong J.L., Legallais C., Darquy S., Reach G. A novel model of solute transport in a hollow-fiber bioartificial pancreas based on a finite element method. Biotechnol. Bioeng. 2002, 78:576-582.
151. Dulong J.L., Legallais C. A theoretical study of oxygen transfer including cell necrosis for the design of a bioartificial pancreas. Biotechnol. Bioeng. 2007, 96:990-998.
152. Dulong J.L., Legallais C. What are the relevant parameters for the geometrical optimization of an implantable bioartificial pancreas?. J. Biomech. Eng. 2005, 127:1054-1061.
153. Colton C.K., Avgoustiniatos E.S. Bioengineering in development of the hybrid artificial pancreas. J. Biomech. Eng. 1991, 113:152-170.
154. Colton C.K. Implantable biohybrid artificial organs. Cell Transplant. 1995, 4:415-436.
155. Avgoustiniatos E.S., Colton C.K. Effect of external oxygen mass transfer resistances on viability of immunoisolated tissue. Ann. N. Y. Acad. Sci. 1997, 31:145-167.
156. Dionne K.E., Colton C.K., Yarmush M.L. Effect of hypoxia on insulin secretion by isolated rat and canine islets of Langerhans. Diabetes 1993, 42:12-21.
157. Reach G., Poussier P., Sausse A., Assan R., Itoh M., Gerich J.E. Functional evaluation of a bioartificial pancreas using isolated islets perifused with blood ultrafiltrate. Diabetes 1981, 30:296-301.
158. Reach G. Bioartificial pancreas. Present state and future prospects. Biomed. Biochim. Acta 1984, 43:569-576.
159. Reach G., Jaffrin M.Y., Desjeux J.F. A U-shaped bioartificial pancreas with rapid glucose-insulin kinetics. In vitro evaluation and kinetic modelling. Diabetes 1984, 33:752-761.
160. Jaffrin M.Y., Reach G., Notelet D. Analysis of ultrafiltration and mass transfer in a bioartificial pancreas. J. Biomech. Eng. 1988, 110:1-10.
161. Reach G., Jaffrin M.Y. Kinetic modelling as a tool for the design of a vascular bioartificial pancreas: feedback between modelling and experimental validation. Comput. Methods Programs Biomed. 1990, 32:277-285.
162. Clayton H.A., James R.F.L., London N.J.M. Islet microencapsulation - a review. Acta Diabetol. 1993, 30:181-189.
163. Gray D.W.R. Encapsulated islet cells - the role of direct and indirect presentation and the relevance to xenotransplantation and autoimmune recurrence. Br. Med. Bull. 1997, 53:777-788.
164. de Vos P., Hamel A.F., Tatarkiewicz K. Considerations for successful transplantation of encapsulated pancreatic islets. Diabetologia 2002, 45:159-173.
165. Narang A.S., Mahato R.I. Biological and biomaterial approaches for improved islet transplantation. Pharmacol. Rev. 2006, 58:194-243.
166. Ponce S., Orive G., Hernández R., Gascón A.R., Pedraz J.L., de Haan B.J., Faas M.M., Mathieu H.J., de Vos P. Biomaterials 2006, 27:4831-4839.
167. Beck J., Angus R., Madsen B., Britt D., Vernon B., Nguyen K.T. Islet encapsulation: strategies to enhance islet cell functions. Tissue Eng. 2006, 589-599.
168. Korsgren O., Nilsson B. Improving islet transplantation - a road map for a widespread application for the cure of persons with type I diabetes. Curr. Opin. Organ Transplant. 2009, 14:683-687.
169. Teramura Y., Iwata H. Bioartificial pancreas microencapsulation and conformal coating of islet of Langerhans. Adv. Drug Deliv. Rev. 2010, 62:827-840.
170. Giraldo J.A., Weaver J.D., Stabler C.L. Enhancing clinical islet transplantation through tissue engineering strategies. J. Diabetes Sci. Technol. 2010, 4:1238-1247.
171. Beck J., Angus R., Madsen B., Britt D., Vernon B., Nguyen K.T. Islet encapsulation: strategies to enhance islet cell function. Tissue Eng. 2006, 1:589-599.
172. Borg D.J., Bonifacio E. The use of biomaterials in islet transplantation. Curr. Diab. Rep. 2011, 11:434-444.
173. Johnson A.S., O'Sullivan E., D'Aoust L.N., Omer A., Bonner-Weir S., Fischer R.J., Weir G.C., Colton C.K. Quantitative assessment of islets of Langerhans encapsulated in alginate. Tissue Eng. Part C Methods 2011, 17:435-449.
174. O'Sullivan E.S., Vegas A., Anderson D.G., Weir G.C. Islets transplanted in immunoisolation devices: a review of the progress and the challenges that remain. Endocr. Rev. 2011, 32:827-844.
175. Sakata N., Sumi S., Yoshimatsu G., Goto M., Egawa S., Unno M. Encapsulated islets transplantation - past, present and future. World J. Gastrointest. Pathophysiol. 2012, 3:19-26.
176. Schleicher L., Barrett G.K., Manifold Record Material. United States Patent 2,730,456, January 10, 1956.
177. Schleicher L., Barrett G.K. Pressure Responsive Record Materials. United States Patent 2,730,457, January 10, 1956.
178. Chang T.M.S. Artificial cells: biotechnology, nanomedicine, regenerative medicine, blood substitutes, bioencapsulation, cell/stem cell therapy. Regenerative Medicine, Artificial Cells and Nanomedicine 2007, vol. 1. World Scientific Publishing Co., Singapore.
179. Chang T.M.S. Hemoglobin corpuscles. Report of a research project for Honours Physiology, Medical Library, McGill University. Also reprinted in: 30th Anniversary in Artificial Red Blood Cells Research. Biomater. Artif. Cells Artif. Organs 1988, 16:1-9.
180. Chang T.M.S. Semipermeable microcapsules. Science 1964, 146:524-525.
181. Chang T.M.S. Semipermeable Aqueous Microcapsules 1965, (Ph. D. thesis), McGill University, Montreal.
182. Chang T.M.S., Macintosh F.C., Mason S.G. Semipermeable aqueous microcapsules: I. Preparation and properties. Can. J. Physiol. Pharmacol. 1966, 44:115-128.
183. Chang, T.M. Nonthrombogenic microcapsules. United States Patent 3,522,346, July 29, 1970.
184. Chang, T.M. Blood compatible microencapsulated detoxicants and method for making. United States Patent 3,725,113, April 3, 1973.
185. Hernandez C.G. The pathophysiology of diabetes mellitus: an update. Diabetes Educ. 1989, 15:162-169.
186. Chang T.M. Hybrid artificial cells: microencapsulation of living cells. ASAIO J. 1992, 38:128-130.
187. Lim F., Sun A.M. Microencapsulated islets as a bioartificial endocrine pancreas. Science 1980, 210:908-910.
188. Martinsen A., Skjak-Braek G., Smidsrod O. Alginate as immobilization material. I. Correlation between chemical and physical properties of alginate gel beads. Biotechnol. Bioeng. 1989, 33:79-89.
189. De Vos P., De Haan B.J., Wolters G.H., Strubbe J.H., Van Schilfgaarde R. Improved biocompatibility but limited graft survival after purification of alginate for micro-encapsulation of pancreatic islets. Diabetologia 1997, 40:262-270.
190. de Vos P., Bucko M., Gemeiner P., Navratil M., Svitel J., Faas M., Strand B.L., Skjak-Braek G., Morch Y.A., Vikartovska A., Lacik I., Kollarikova G., Orive G., Poncelet D., Pedraz J.L., Ansorge-Schumacher M.B. Multiscale requirements for bioencapsulation in medicine and biotechnology. Biomaterials 2009, 30:2559-2570.
191. Morch Y.A., Donati I., Strand B.L., Skjak-Braek G. Effect of Ca2+, Ba2+, Sr2+ on alginate microbeads. Biomacromolecules 2006, 7:1471-1480.
192. Omer A., Duvivier-Kali V., Fernandes J., Tchipashvili V., Colton C.K., Weir G.C. Long-term normoglycemia in rats receiving transplants with encapsulated islets. Transplantation 2005, 79:52-58.
193. Safley S.A., Cui H., Cauffiel S., Tucker-Burden C., Weber C.J. Biocompatibility and immune acceptance of adult porcine islets transplanted intraperitoneally in diabetic NOD mice in calcium alginate poly-l-lysine microcapsules versus barium alginate microcapsules without poly-l-lysine. J. Diabetes Sci. Technol. 2008, 2:760-767.
194. McKenzie I.F., Xing P.X., Vaughan H.A., Prenzoska J., Dabkowski P.L., Sandrin M.S. Distribution of the major xenoantigen (gal (α1-3)gal) for pig to human xenografts. Transpl. Immunol. 1994, 2:81-86.
195. Omer A., Duvivier-Kali V.F., Trivedi N., Wilmot K., Bonner-Weir S., Weir G.C. Survival and maturation of micro-encapsulated porcine neonatal pancreatic cell clusters transplanted into immunocompetent diabetic mice. Diabetes 2003, 52:69-75.
196. Duvivier-Kali V.F., Omer A., Lopez-Avalos M.D., O'Neil J.J., Weir G.C. Survival of microencapsulated adult pig islets in mice in spite of an antibody response. Am. J. Transplant. 2004, 4:1991-2000.
197. Soon-Shiong P., Feldman E., Nelson R., Heintz R., Yao Q., Yao Z., Zheng T., Merideth N., Skjak-Braek G., Espevik T. Long-term reversal of diabetes by the injection of immunoprotected islets. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:5843-5847.
198. Sun Y., Ma X., Zhou D., Vacek I., Sun A.M. Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. J. Clin. Invest. 1996, 98:1417-1422.
199. Calafiore R., Basta G., Luca G., Lemmi A., Montanucci M.P., Calabrese G., Racanicchi L., Mancuso F., Brunetti P. Microencapsulated pancreatic islet allografts into nonimmunosuppressed patients with type 1 diabetes: first two cases. Diabetes Care 2006, 29:137-138.
200. Tuch B.E., Keogh G.W., Williams L.J., Wu W., Foster J.L., Vaithilingam V., Philips R. Safety and viability of microencapsulated human islets transplanted into diabetic humans. Diabetes Care 2009, 32:1887-1889.
201. Elliott R.B., Escobar L., Tan P.L., Muzina M., Zwain S., Buchanan C. Live encapsulated porcine islets from a type 1 diabetic patient 9.5yr after xenotransplantation. Xenotransplantation 2007, 14:157-161.
202. Dufrane D., Goebbels R.M., Saliez A., Guiot Y., Gianello P. Six-month survival of microencapsulated pig islets and alginate biocompatibility in primates: proof of concept. Transplantation 2006, 81:1345-1353.
203. Lim F., Moss R.D. Microencapsulation of living cells and tissues. J. Pharm. Sci. 1981, 70:351-354.
204. Van Schilfgaarde R., de Vos P. Factors influencing the properties and performance of microcapsules for immunoprotection of pancreatic islets. J. Mol. Med. 1999, 77:199-205.
205. Strand B.L., Ryan T.L., In't Veld P., Kulseng B., Rokstad A.M., Skjak-Brek G., Espevik T. Poly-l-lysine induces fibrosis on alginate microcapsules via the induction of cytokines. Cell Transplant. 2001, 10:263-275.
206. King A., Lau J., Nordin A., Sandler S., Andersson A. The effect of capsule composition in the reversal of hyperglycemia in diabetic mice transplanted with microencapsulated allogeneic islets. Diabetes Technol. Ther. 2003, 5:653-663.
207. Ponce S., Orive G., Hernandez R., Gascon A.R., Pedraz J.L., de Hahn B.J., Faas M.M., Mathieu H.J., de Vos P. Chemistry and the biological response against immunoisolating alginate-polycation capsules of different composition. Biomaterials 2006, 27:4831-4839.
208. Bunger C.M., Teifenbach B., Jahnke A., Gerlach C., Freier T., Schmitz K.P., Hopt U.Y., Schareck W., Klar E., de Vos P. Deletion of tissue response against alginate-PLL capsules by temporary release of co-encapsualted steroids. Biomaterials 2005, 26:2353-2360.
209. Duvivier-Kali V.F., Omer A., Parent R.J., O'Neil J.J., Weir G.C. Complete protection of islets against allorejection and autoimmunity by a simple basirum-alginate membrane. Diabetes 2001, 50:1698-1705.
210. Goosen M.F.A., O'Shea G.M., Gharapetian H.M., Chou S., Sun A.M. Optimization of microencapsulation parameters - semi-permeable microcapsules as a bioartificial pancreas. Biotechnol. Bioeng. 1985, 27:146-150.
211. McDowell R.H. Properties of Alginates 1986, Kelco International, London. 5th edn.
212. O'Shea G.M., Goosen M.F.A., Sun A.M. Prolonged survival of transplanted islets of Langerhans encapsulated in a biocompatible membrane. Biochim. Biophys. Acta 1984, 804:133-136.
213. Sun A.M., O'Shea G.M. Transplantation of microencapsulated islets of Langerhans as an insulin delivery system. Topics in Pharmaceutical Sciences 1985. Proceedings of the 45th International Congress of Pharmaceutical Sciences of FIP 1985, 99-100. Elsevier, Amsterdam. D.D. Breimer, P. Speiser (Eds.).
214. Bergan J.J., Yao J.S.T., Flinn W.R., Graham L.M. Prosthetic grafts for the treatment of lower limb ischaemia - present status. Br. J. Surg. 1982, 69:34-37.
215. Sun A.M., O'Shea G.M., Goosen M.F.A. Injectable microencapsulated islet cells as a bioartificial pancreas. Appl. Biochem. Biotechnol. 1984, 10:87-99.
216. Sun A.M., Goosen M.F.A., O'Shea G. Microencapsulated cells as hormone delivery systems. Crit. Rev. Ther. Drug Carrier Syst. 1987, 4:1-12.
217. Calafiore R., Koh N., Civantos F., Shienvold F.L., Needell S.D., Alejandro R. Xenotransplantation of microencapsulated canine islets in diabetic mice. Trans. Assoc. Am. Physicians 1986, 99:28-33.
218. Chicheportiche D., Darquy S., Lepeintre J., Capron F., Halban P.A., Reach G. High-performance liquid chromatography analysis of circulating insulins distinguishes between endogenous insulin production (a potential pitfall with streptozotocin diabetic rats) and islet xenograft function. Diabetologia 1990, 33:457-461.
219. Weber C.J., Zabinski S., Koschitzky T., Wicker L., Rajotte R., D'Agati V., Peterson L., Norton J., Reemtsma K. The role of CD4+ helper T cells in the destruction of microencapsulated islet xenografts in NOD mice. Transplantation 1990, 49:396-404.
220. Ricker A.T., Stockberger S.M., Halban P.A., Eisenbarth G.S., Bonner-Weir S. Hyperimmune response to microencapsulated xenogenic tissue in non-obese diabetic mouse. The Immunology of Diabetes Mellitus 1986, 193-200. Elsevier, Amsterdam. M.A. Jaworski, G.D. Molnar, R.V. Rajotte, B. Singh (Eds.).
221. Calafiore R., Koh N., Alejandro R., Civantos F., Shyr A., Tsang W.G. Xenotransplantation of microencapsulated canine islets in diabetic mice. Advanced Models for the Therapy of Insulin-dependent Diabetes 1987, 353-357. Raven Press, New York. P. Brunetti, W.K. Wladhausl (Eds.).
222. Soon-Shiong P. Treatment of type I diabetes using encapsulated islets. Adv. Drug Deliv. Rev. 1999, 35:259-270.
223. Soon-Shiong P., Heintz R.E., Merideth N., Yao Q.X., Yao Z., Zheng T., Murphy M., Moloney M.K., Schmehl M., Harris M. Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet 1994, 343:950-951.
224. Soon-Shiong P., Feldman E., Nelson R., Komtebedde J., Smidsrod O., Skjak-Braek G., Espevik T., Heintz R., Lee M. Successful reversal of spontaneous diabetes in dogs by intraperitoneal microencapsulated islets. Transplantation 1992, 54:769-774.
225. Wolters G.H., Fritschy W.M., Gerrits D., van Schilfgaarde R. A versatile alginate droplet generator applicable for microencapsulation of pancreatic islets. J. Appl. Biomater. 1991, 3:281-286.
226. Desai T.A., West T., Cohen M., et al. Nanoporous microsystems for islet cell replacement. Adv. Drug Deliv. Rev. 2004, 56:1661.
227. Loscertales I.G., Barrero A., Guerrero I., et al. Micro/nano encapsulation via electrified coaxial liquid jets. Science 2002, 295:1695.
228. de Vos P., De Haan B., Wolters G.H., van Schilfgaarde R. Factors influencing the adequacy of microencapsulation of rat pancreatic islets. Transplantation 1996, 62:888-893.
229. Silva A.I., de Matos A.N., Brons I.G., Mateus M. An overview on the development of a bio-artificial pancreas as a treatment of insulin-dependent diabetes mellitus. Med. Res. Rev. 2006, 26:181-222.
230. Uludag H., de-Vos P., Tresco P.A. Technology of mammalian cell encapsulation. Adv. Drug Deliv. Rev. 2000, 42:29-64.
231. De Vos P., Wolters G.H., Fritschy W.M., Van Schilfgaarde R. Obstacles in the application of microencapsulation in islet transplantation. Int. J. Artif. Organs 1993, 16:205-212.
232. Hobbs H.A., Kendall W.F., Darrabie M., Opara E.C. Prevention of morphological changes in alginate micro-capsules for islet xenotransplantation. J. Investig. Med. 2001, 49:572-575.
233. Ar'Rajab A., Bengmark S., Ahren B. Insulin secretion in steptozotocin-diabetic rats transplanted with immunoisolated islets. Transplantation 1991, 51:570-574.
234. Dorian, R.E., Cochrum, K.C. Cells or tissue coated with non-fibrogenic alginate less than 200 uM thick. United States Patent 5,656,468, August 12, 1997.
235. Dorian, R.E., Cochrum, K.C. Microcapsule generating system containing an air knife and method of encapsulating. United States Patent 5,521,079, May 28, 1996.
236. Dorian, R.E., Cochru, K.C., Antanavich, R.D. Spin encapsulation apparatus and method of use. United States Patent 5,643,594, July 1, 1997.
237. Zekorn T., Siebers U., Horcher A., Schnettler R., Zimmermann U., Bretzel R.G., Federlin K. Alginate coating of islets of Langerhans: in vitro studies on a new method for microencapsulation for immune-isolated transplantation. Acta Diabetol. 1992, 29:41-45.
238. Tendulkar S., McQuilling J.P., Childers C., Pareta R., Opera E.C., Ramasurbramanian M.K. A scalable micro-fluidic device for the mass production of microencapsulated islets. Transplant. Proc. 2011, 43:3184-3187.
239. Duvivier-Kali V.F., Omer A., Lopez-Avalos M.D., O'Neil J.J., Weir G.C. Survival of microencapsulated adult pit islets in mice in spite of an antibody response. Am. J. Transplant. 2004, 4:1991-2000.
240. Calafiore R., Basta G., Luca G., Boselli C., Bufalari A., Bufalari A., Cassarani M.P., Giustozzi G.M., Brunetti P. Transplantation of pancreatic islets contained in minimal volume microencapsules in diabetic high mammalians. Ann. N. Y. Acad. Sci. 1999, 18:219-232.
241. Calafiore R., Luca G., Calvitti M., Neri L.M., Basta G., Capitani S., Becchetti E., Brunetti P. Cellular support systems for alginate microcapsules containing islets, as composite bioartificial pancreas. Ann. N. Y. Acad. Sci. 2001, 944:240-251.
242. Calafiore R. Alginate microcapsules for pancreatic islet cell graft immunoprotection: struggle and progress towards the final cure for type 1 diabetes mellitus. Expert Opin. Biol. Ther. 2003, 3:201-205.
243. Calafiore R., Basta G., Luca G., Calvitti M., Calabrese G., Racanicchi L., Macchiarulo G., Mancuso F., Guido L., Brunetti P. Grafts of microencapsulated pancreatic islet cells for the therapy of diabetes mellitus in non-immunosuppressed animals. Biotechnol. Appl. Biochem. 2004, 39:159-164.
244. Basta G., Sarchielli P., Luca G., Racanicchi L., Nastruzzi C., Guido L., Mancuso F., Macchiarulo G., Calabrese G., Brunetti P., Calafiore R. Optimized parameters for microencapsulation of pancreatic islet cells: an in vitro study clueing on islet graft immunoprotection in type 1 diabetes mellitus. Transpl. Immunol. 2004, 13:289-296.
245. Elliott R.B., Escobar L., Calafiore R., Basta G., Garkavenko O., Vasconcellos A., Bambra C. Transplantation of micro- and macroencapsulated piglet islets into mice and monkeys. Transplant. Proc. 2005, 37:466-469.
246. Mazzitelli S., Tosi A., Balestra C., Nastruzzi C., Luca G., Mancuso F., Calafiore R., Calvitti M. Production and characterization of alginate microcapsules produced by a vibrational encapsulated device. J. Biomater. Appl. 2008, 23:123-145.
247. Luca G., Calvitti M., Neri L.M., Becchetti E., Capitani S., Basta G., Angeletti G., Fanelli C., Brunetti P., Calafiore R. Sertoli cell-induced reversal of adult rat pancreatic islet beta-cells into fetal-like status: potential implications for islet transplantation in type I diabetes mellitus. J. Investig. Med. 2000, 48:441-448.
248. Luca G., Calvitti M., Neri L.M., Basta G., Brozzetti A., Saturni A., Mughetti D., Becchetti E., Capitani S., Brunetti P., Calafiore R. Mitogenic effects of rat Sertoli cells on adult homologous islet beta-cells: in vitro and in vivo studies. Transplant. Proc. 2001, 33:681-682.
249. Luca G., Calvitti M., Baroni T., Basta G., Angeletti G., Neri L.M., Becchetti E., Capitani S., Brunetti P., Calafiore R. Sertoli cell-induced adult rat islet beta-cell mitogenesis: causative pathways. Diabetes Nutr. Metab. 2003, 16:1-6.
250. Luca G., Calvitti M., Nastruzzi C., Macchiarulo G., Becchetti E., Neri L.M., Capitani S., Basta G., Brunetti P., Calafiore R., Cameron D.F. Effects of simulated microgravity on the morphology and function of neonatal porcine cell clusters cultured with and without Sertoli cells. Cell Transplant. 2006, 15:55-65.
251. Luca G., Calvitti M., Nastruzzi C., Bilancetti L., Becchetti E., Angeletti G., Mancuso F., Calafiore R. Encapsulation, in vitro characterization, and in vivo biocompatibility of Sertoli cells in alginate-based microcapsules. Tissue Eng. 2007, 13:641-648.
252. Mancuso F., Calvitti M., Luca G., Nastruzzi C., Baroni T., Mazzitelli S., Becchetti E., Arato I., Boselli C., Ngo Nselel M.D., Calafiore R. Acceleration of functional maturation and differentiation of neonatal porcine islet cell monolayers shortly in vitro cocultured with microencapsulated sertoli cells. Stem Cells Int. 2009, 2010:587213.
253. Calafiore R., Basta G., Luca G., Lemmi A., Racanicchi L., Mancuso F., Montanucci M.P., Brunetti P. Standard technical procedures for microencapsulation of human islets for graft into nonimmunosuppressed patients with type 1 diabetes mellitus. Transplant. Proc. 2006, 38:1156-1157.
254. Basta G., Montanucci P., Luca G., Boselli C., Noya G., Barbaro B., Qi M., Kinzer K.P., Oberholzer J., Calafiore R. Long-term metabolic and immunological follow-up of nonimmunosuppressed patients with type 1 diabetes treated with microencapsulated islet allografts: four cases. Diabetes Care 2011, 34:2406-2409.
255. O'Sullivan E.S., Johnson A.S., Omer A., Hollister-Lock J., Bonner-Weir S., Colton C.K., Weir G.C. Rat islet cell aggregates are superior to islets for transplantation in micro-capsules. Diabetologia 2010, 53:937-945.
256. Wang T., Adcock J., Kuhtreiber W., Qiang D., Salleng K.J., Trenary I., Williams P. Successful allotransplantation of encapsulated islets in pancreatectomized canines for diabetic management without the use of immunosuppression. Transplantation 2008, 85:331-337.
257. Elliott R.B., Escobar L., Tan P.L., Garkavenko O., Calafiore R., Basta P., Vasconcellos A.V., Emerich D.F., Thanos C., Bambra C. Intraperitoneal alginate-encapsulated neonatal porcine islets in a placebo-controlled study with 16 diabetic cynomolgus primates. Transplant. Proc. 2005, 37:3505-3508.
258. Berman D.M., O'Neil J.J., Coffey L.C., Chaffanjon P.C., Kenyon N.M., Ruiz P., Pileggi A., Ricordi C., Kenyon N.S. Long-term survival of nonhuman primate islets implanted in an omental pouch on a biodegradable scaffold. Am. J. Transplant. 2009, 9:91-104.
259. Skinner S.J.M., Tan P.L.J., Garkavenko O., Muzina M., Escobar L., Elliott R.B. Cell replacement therapy: the rationale for encapsulated porcine islet transplantation. Type 1 Diabetes Complications 2011, In Tech Europe, Croatia. D. Wagner (Ed.).
260. Safley S.A., Kapp L.M., Tucker-Burden C., Hering B., Kapp J.A., Weber C.J. Inhibition of cellular immune responses to encapsulated porcine islet xenografts by simultaneous blockade of two different costimulatory pathways. Transplantation 2005, 79:409-418.
261. Cui H., Tucker-Burden C., Cauffiel S.M., Barry A.K., Iwakoshi N.N., Weber C.J., Safley S.A. Long-term metabolic control of autoimmune diabetes in spontaneously diabetic nonobese diabetic mice by nonvascularized microencapsulated adult porcine islets. Transplantation 2009, 88:160-169.
262. Iwata H., Amamiya H., Masuda T., Takano H., Akutsu T. Microencapsulation of Langerhans islets in agarose microbeads and their application for a bioartificial pancreas. J. Bioact. Compat. Polym. 1988, 3:356-369.
263. Dupuy B., Gin H., Baquey C., Ducassou D. In situ polymerization of a microencapsulating medium around living cells. J. Biomed. Mater. Res. 1988, 22:1061-1070.
264. Iwata H., Kobayashi K., Takagi T., Oka T., Yang H., Amemiya H., Tsuji T., Ito F. Feasibility of agarose microbeads with xenogenic islets as a bioartificial pancreas. J. Biomed. Mater. Res. 1994, 28:1003-1011.
265. Rajotte R.V., Scharp D.W., Downing R., Preston R., Molnar G.D., Ballinger W.F. Pancreatic islet banking: the transplantation of frozen-thawed rat islets transported between centers. Cryobiology 1981, 18:357-369.
266. Carlos A.G., Teramura Y., Iwata H. Cryopreserved agarose-encapsulated islets as a bioartificial pancreas: a feasibility study. Transplantation 2009, 87:29-34.
267. Wang T., Lacik I., Brissova M., Anilkumar A.V., Prokop A., Hunkeler D., Green R., Shahrokhi K., Powers A.C. An encapsulation system for the immunoisolation of pancreatic islets. Nat. Biotechnol. 1997, 15:358-362.
268. Lacik I., Brissova M., Anilkumar A.V., Powers A.C., Wang T. New capsule with tailored properties for the encapsulation of living cells. J. Biomed. Mater. Res. 1998, 39:52-60.
269. Brissova M., Lacik I., Powers A.C., Anilkumar A.V., Wang T. Control and measurement of permeability for design of microcapsule cell delivery system. J. Biomed. Mater. Res. 1998, 39:61-70.
270. Wang T.G. New technologies for bioartificial organs. Artif. Organs 1998, 22:68-74.
271. Powers A.C., Brissova M., Lacik I., Anilkumar A.V., Shahrokhi K., Wang T.G. Permeability assessment of capsules for islet transplantation. Ann. N. Y. Acad. Sci. 1997, 31:208-216.
272. Poncelet D., Lencki R., Beaulieu C., Halle J.P., Neufeld R.J., Fournier A. Production of alginate beads by emulsion/internal gelation. I. Methodology. Appl. Microbiol. Biotechnol. 1992, 32:39-42.
273. Hoesli C.A., Raghuram K., Kiang R.L.J., Mocinecova D., Hu X., Johnson J.D., Lacik I., Kieffer T.J., Piret J.M. Pancreatic cell immobilization in alginate beads produced by emulsion and internal gelation. Biotechnol. Bioeng. 2011, 108:424-434.
274. Hoesli C.A., Kiang R.L.J., Mocinecova D., Speck M., Moskova D.J., Donald-Hague C., Lacik I., Kieffer T.J., Piret J.M. Reversal of diabetes by bTC3 cells encapsulated in alginate beads generated by emulsion and internal gelation. J. Biomed. Mater. Res. B 2012, 100B:1017-1028.
275. Cruise G.M., Hegre O.D., Scharp D.W., Hubbell J.A. A sensitivity study of the key parameters in the interfacial photopolymerization of poly (ethylene glycol) diacrylate upon porcine islets. Biotechnol. Bioeng. 1998, 57:655-665.
276. Cruise G.M., Scharp D.W., Hubbell J.A. Characterization of permeability and network structure of interfacially photopolymerized poly(ethylene glycol) diacrylate hydrogels. Biomaterials 1998, 19:1287-1294.
277. Cruise G.M., Hegre O.D., Lamberti F.V., Hager S.R., Hill R., Scharp D.W., Hubbell J.A. In vitro and in vivo performance of porcine islets encapsulated in interfacially photopolymerized poly(ethylene glycol) diacrylate membranes. Cell Transplant. 1999, 8:293-306.
278. Hill R.S., Cruise G.M., Hager S.R., Lamberti F.V., Yu X., Garufis C.L., Yu Y., Mundwiler K.E., Cole J.F., Hubbell J.A., Hegre O.D., Scharp D.W. Immunoisolation of adult porcine isles for the treatment of diabetes mellitus. Ann. N. Y. Acad. Sci. 1997, 831:332-343.
279. Scharp D., Yu X., Sheckler V., Hubbell J., Latta P. Clinically relevant results from encapsulated islet allografts implanted subcutaneously in diabetic baboons without long term immunosuppression. Diabetes 2005, 54. (Sup 194-OR).
280. Marigliano M., Casu A., Bertera S., Trucco M., Botino R. Hemoglobin A1C percentage in nonhuman primates: a useful tool to monitor diabetes before and after porcine pancreatic islet xenotransplantation. J. Transplant. 2011, 8. (965605).
281. Scharp D., Schwartz S., Mulgrew P., Albrecht G., Oberlholzer J., Kuhtreiber W., Yu X. Encapsulated human islet allografts: phase I/II clinical trial. Diabetes 2006, 55. (Suppl.).
282. Rodolfo A., Barton F.B., Hering B.J., Wease S. Update from the collaborative islet transplant registry. Transplantation 2008, 86:1783-1788.
283. Alejandro R., Barton F.B., Hering B.J., Wease S. 2008 Update From the Collaborative Islet Transplant Registry. Transplantation 2008, 86:1783-1788.
284. Kirby A., Bohman S., Westberg H., Jones P., King A. Immunoisolation of islets in high guluronic acid barium-alginate microcapsules does not improve graft outcome at the subcutaneous site. Artif. Organs 2012, 36:564-570.
285. Pickup J.C., Zheng-Liang Z., Khan F., Saxl T., Birch D.J.S. Nanomedicine and its potential in diabetes research and practice. Diabetes Metab. Res. Rev. 2008, 24:604-610.
286. Krol S., de Guerra S., Grupillo M., Diaspro A., Gliozzi A., Marchetti P. Multilayer nanocapsules: new approach for immune protection of human pancreatic islets. Nano Lett. 2006, 6:1933-1936.
287. Teramura Y., Kaneda Y., Iwata H. Islet-encapsulation in ultra-thin layer-by-layer membranes of poly(vinyl alcohol) anchored to poly(ethylene glycol)-lipids in the cell membrane. Biomaterials 2007, 28:4818-4825.
288. Wilson J.T., Cui W., Chalkoff E.L. Layer-by-layer assembly of a conformal PEG coating for intraportal islet transplantation. Nano Lett. 2008, 8:1940-1948.
289. Kizilel S., Scavobe A., Liu X., Nothias J.M., Ostrega D., Witkowsli P., Millis M. Encapsulation of pancreatic islets within nano-thin functional polyethylene glycol coatings for enhanced insulin secretion. Tissue Eng. Part A 2010, 16:2217-2228. (Barton FB, Rickels MR, Alejandro R, Hering BJ, Wease S, Naziruddin B, Oberholzer J, Odorico JS, Garfinkel MR, Levy M, Pattou F, Berney T, Secchi A, Messinger S, Senior PA, Maffi P, Posselt A, Stock PG, Kaufman DB, Luo X, Kandeel F, Cagliero E, Turgeon NA, Witkowski P, Naji A, O'Connell PJ, Greenbaum C, Kudva YC, Brayman KL, Aull MJ, Larsen C, Kay TW, Fernandez LA, Vantyghem MC, Bellin M, Shapiro AM).
290. Zhi Z.I., Kerby A., King A.J.F., Jones P.M., Pickup J.C. Nano-scale encapsulation enhances allograft survival and function of islets transplanted in a mouse model of diabetes. Diabetologia 2012, 55:1081-1090.
291. Dong H., Fahmy T.M., Metcalfe S.M., Morton S.L., Dong X., Inverardi L., Adams D.B., Gao W., Wang H. Immuno-isolation of pancreatic islet allografts using pegylated nanotherapy leads to long-term normoglycemia in full MHC mismatch recipient mice. PLoS ONE 2012, 7:e50265.
292. Kozlovskaya V., Zavgorodnya O., Kharlampieva E. Encapsulation and surface engineering of pancreatic islets: advances and challenges. Biomedicine 2012, 1-34. In Tech Europe, Croatia. C. Lin (Ed.).
293. Teramura Y., Iwata H. Islet encapsulation with living cells for improvement of biocompatibility. Biomaterials 2009, 30:2270-2275.
294. Lee J.I., Nishimura R., Sakai H., Sasaki N., Kenmochi T. A newly developed immunoisolated bioartificial pancreas with cell sheet engineering. Cell Transplant. 2008, 17:51-59.
295. Pollok J.M., Lorenzen M., Kolln P.A., Torok E., Kaufmann P.M., Kluth D., et al. In vitro function of islets of Langerhans encapsulated with a membrane of porcine chondrocytes for immunoisolation. Dig. Surg. 2001, 18:204-210.
296. Teramura Y., Minh L.N., Kawamoto T., Iwata H. Microencapsulation of islets with living cells using polyDNA-PEG-lipid conjugate. Bioconjug. Chem. 2010, 21:792-796.
297. Korsgren O., Nilsson B., Berne C., Felldin M., Foss A., Kallen R., Lundgren T., Salmela K., Tibell A., Tufveson G. Current status of clinical islet transplantation. Transplantation 2005, 79:1289-1293.
298. Bennet W., Groth C.G., Larsson R., Nilsson B., Korsgren O. Isolated human islets trigger an instant blood mediated inflammatory reaction: implications for intraportal islet transplantation as a treatment for patients with type 1 diabetes. Ups. J. Med. Sci. 2000, 105:125-133.
299. van der Windt D.J., Bottino R., Casu A., Campanile N., Cooper D.K. Rapid loss of intraportally transplanted islets: an overview of pathophysiology and preventive strategies. Xenotransplantation 2007, 14:288-297.
300. Gibly R.F., Graham J.G., Luo X., Lowe W.L., Hering B.J., Shea L.D. Advancing islet transplantation: from engraftment to the immune response. Diabetologia 2011, 54:2494-2505.
301. Robson S.C., Cooper D.K., d'Apice A.J. Disordered regulation of coagulation and platelet activation in xenotransplantation. Xenotransplantation 2000, 7:166-176.
302. Nilsson B., Ekdahl K.N., Korsgren O. Control of instant blood-mediated inflammatory reaction to improve islets of Langerhans engraftment. Curr. Opin. Organ Transplant. 2011, 16:620-626.
303. Ma X., Ye B., Gao F., Liang Q., Dong Q., Liu Y., Rong P., Wang W., Yi S. Tissue factor knockdown in porcine islets: an effective approach to suppressing the instant blood-mediated inflammatory reaction. Cell Transplant. 2012, 21:61-71.
304. Teramura Y., Iwata H. Islets surface modification prevents blood-mediated inflammatory responses. Bioconjug. Chem. 2008, 19:1389-1395.
305. Teramura Y., Iwata H. Surface modification of islets with PEG-lipid for improvement of graft survival in intraportal transplantation. Transplantation 2009, 88:624-630.
306. Teramura Y., Iwata H. Improvement of graft survival by surface modification with poly(ethylene glycol)-lipid and urokinase in intraportal islet transplantation. Transplantation 2011, 91:271-278.
307. Chen H., Teramura Y., Iwata H. Co-immobilization of urokinase and thrombomodulin on islet surfaces by poly(ethylene glycol)-conjugated phospholipid. J. Control. Release 2011, 150:229-234.
308. Luan N.M., Teramura Y., Iwata H. Layer-by-layer co-immobilization of soluble complement receptor 1 and heparin on islets. Biomaterials 2011, 32:6487-6492.
309. Hwang J.W., Jung H.S., Lee D.Y. Inhibition of platelet adhesion onto intrahepatically transplanted islets using PEGylation for attenuating instant blood-mediated inflammatory reaction (IBMIR). J. Control. Release 2011, 152(Suppl. 1):e213-e412.
310. Kim J.H., Oh B.J., Lee H.N., Park H.S., Park S.G., Park K.S. Endothelial colony-forming cell coating of pig islets prevents xenogeneic instant blood-mediated inflammatory reaction. Cell Transplant. 2011, 20:1805-1815.
311. Im B.H., Jeong J.H., Haque M.R., Lee D.Y., Ahn C.H., Kim J.E., Byun Y. The effects of 8-arm-PEG-catechol/heparin shielding system and immunosuppressive drug, FK506 on the survival of intraportally allotransplanted islets. Biomaterials 2013, 34:2098-2106.
312. Sibley R.K., Sutherland D.E., Goetz F., Michael A.F. Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. Lab. Invest. 1985, 53:132-144.
313. Burke G.W., Vendrame F., Pileggi A., Ciancio G., Reijonen H., Pugliese A. Recurrence of autoimmunity following pancreas transplantation. Curr. Diab. Rep. 2011, 11:413-419.
314. Harlan D.M., Kenyon N.S., Korsgren O., Roep B.O. Immunology of Diabetes Society. Current advances and travails in islet transplantation. Diabetes 2009, 58:2175-2184.
315. Hilbrands R., Huurman V.A., Gillard P., Velthuis J.H., De Waele M., Mathieu C., Kaufman L., Pipeleers-Marichal M., Ling Z., Movahedi B., Jacobs-Tulleneers-Thevissen D., Monbaliu D., Ysebaert D., Gorus F.K., Roep B.O., Pipeleers D.G., Keymeulen B. Differences in baseline lymphocyte counts and autoreactivity are associated with differences in outcome of islet cell transplantation in type 1 diabetic patients. Diabetes 2009, 58:2267-2276.
316. Vaithilingam V., Tuch B.E. Islet transplantation and encapsulation: an update on recent developments. Rev. Diabet. Stud. 2011, 8:51-67.
317. Kumagai-Braesch M., Jacobson S., Mori H., Jia X., Takahashi T., Wernerson A., Flodström-Tullberg M., Tibell A. The TheraCyte(TM) device protects against islet allograft rejection in immunized hosts. Cell Transplant. 2012, 10.3727/096368912X657486.
318. Kobayashi T., Aomatsu Y., Iwata H., Kin T., Kanehiro H., Hisanga M., Ko S., Nagao M., Harb G., Nakajima Y. Survival of microencapsulated islets at 400days posttransplantation in the omental pouch of NOD mice. Cell Transplant. 2006, 15:359-365.
319. Duvivier-Kali V.F., Omer A., Parent R.J., O'Neil J.J., Weir G.C. Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane. Diabetes 2001, 50:1698-1705.
320. Vaithilingam V., Quayum N., Joglekar M.V., Jensen J., Hardikar A.A., Oberholzer J., Guillemin G.J., Tuch B.E. Effect of alginate encapsulation on the cellular transcriptome of human islets. Biomaterials 2011, 32:8416-8425.
321. (accessed on February 15, 2013). http://www.clinicaltrials.gov.
322. Pierson R.N. Antibody-mediated xenograft injury: mechanisms and protective strategies. Transpl. Immunol. 2009, 21:65-69.
323. Scalea J., Hanecamp I., Robson S.C., Yamada K. T-cell-mediated immunological barriers to xenotransplantation. Xenotransplantation 2012, 19:23-30.
324. Söderlund J., Wennberg L., Castaños-Velez E., Biberfeld P., Zhu S., Tibell A., Groth C.G., Korsgren O. Fetal porcine islet-like cell clusters transplanted to cynomolgus monkeys: an immunohistochemical study. Transplantation 1999, 67:784-791.
325. Kirchhof N., Shibata S., Wijkstrom M., Kulick D.M., Salerno C.T., Clemmings S.M., Heremans Y., Galili U., Sutherland D.E., Dalmasso A.P., Hering B.J. Reversal of diabetes in non-immunosuppressed rhesus macaques by intraportal porcine islet xenografts precedes acute cellular rejection. Xenotransplantation 2004, 11:396-407.
326. Komoda H., Miyagawa S., Kubo T., Kitano E., Kitamura H., Omori T., Ito T., Matsuda H., Shirakura R. A study of the xenoantigenicity of adult pig islets cells. Xenotransplantation 2004, 11:237-246.
327. Bühler L., Deng S., O'Neil J., Kitamura H., Koulmanda M., Baldi A., Rahier J., Alwayn I.P., Appel J.Z., Awwad M., Sachs D.H., Weir G., Squifflet J.P., Cooper D.K., Morel P. Adult porcine islet transplantation in baboons treated with conventional immunosuppression or a non-myeloablative regimen and CD154 blockade. Xenotransplantation 2002, 9:3-13.
328. Cantarovich D., Blancho G., Potiron N., Jugeau N., Fiche M., Chagneau C., Letessier E., Boeffard F., Loth P., Karam G., Soulillou J.P., Le Mauff B. Rapid failure of pig islet transplantation in non human primates. Xenotransplantation 2002, 9:25-35.
329. de Vos P., Marchetti P. Encapsulation of pancreatic islets for transplantation in diabetes: the untouchable islets. Trends Mol. Med. 2002, 8:363-366.
330. Dufrane D., Gianello P. Macro- or microencapsulation of pig islets to cure type 1 diabetes. World J. Gastroenterol. 2012, 18:6885-6893.
331. Lanza R.P., Beyer A.M., Chick W.L. Xenogenic humoral responses to islets transplanted in biohybrid diffusion chambers. Transplantation 1994, 57:1371-1375.
332. Kobayashi T., Harb G., Rajotte R.V., Korbutt G.S., Mallett A.G., Arefanian H., Mok D., Rayat G.R. Immune mechanisms associated with the rejection of encapsulated neonatal porcine islet xenografts. Xenotransplantation 2006, 13:547-559.
333. Tam S.K., de Haan B.J., Faas M.M., Hallé J.P., Yahia L., de Vos P. Adsorption of human immunoglobulin to implantable alginate-poly-l-lysine microcapsules: effect of microcapsule composition. J. Biomed. Mater. Res. A 2009, 89:609-615.
334. van der Windt D.J., Bottino R., Kumar G., Wijkstrom M., Hara H., Ezzelarab M., Ekser B., Phelps C., Murase N., Casu A., Ayares D., Lakkis F.G., Trucco M., Cooper D.K. Clinical islet xenotransplantation: how close are we?. Diabetes 2012, 61:3046-3055.
335. Ekser B., Ezzelarab M., Hara H., van der Windt D.J., Wijkstrom M., Bottino R., Trucco M., Cooper D.K. Clinical xenotransplantation: the next medical revolution?. Lancet 2012, 379:672-683.
336. Valdés-González R.A., Dorantes L.M., Garibay G.N., Bracho-Blanchet E., Mendez A.J., Dávila-Pérez R., Elliott R.B., Terán L., White D.J. Xenotransplantation of porcine neonatal islets of Langerhans and Sertoli cells: a 4-year study. Eur. J. Endocrinol. 2005, 153:419-427.
337. Birmingham K. Skepticism surrounds diabetes xenograft experiment. Nat. Med. 2002, 8:1047.
338. Dufrane D., Goebbels R.M., Gianello P. Alginate macroencapsulation of pig islets allows correction of streptozotocin-induced diabetes in primates up to 6months without immunosuppression. Transplantation 2010, 90:1054-1062.
339. (accessed on February 15, 2013). http://www.lctglobal.com.
340. Graham M.L., Bellin M.D., Papas K.K., Hering B.J., Schuurman H.J. Species incompatibilities in the pig-to-macaque islet xenotransplant model affect transplant outcome: a comparison with allotransplantation. Xenotransplantation 2011, 18:328-342.
341. Henquin J.C. Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 2000, 49:1751-1760.
342. Rutter G.A., Varadi A., Tsuboi T., Parton L., Ravier M. Insulin secretion in health and disease: genomics, proteomics and single vesicle dynamics. Biochem. Soc. Trans. 2006, 34:247-250.
343. Marchetti P., Dotta F., Lauro D., Purrello F. An overview of pancreatic beta-cell defects in human type 2 diabetes: implications for treatment. Regul. Pept. 2008, 146:4-11.
344. Seino S., Shibasaki T., Minami K. Dynamics of insulin secretion and the clinical implications for obesity and diabetes. J. Clin. Invest. 2011, 121:2118-2125.
345. Marchetti P., Scharp D.W., Mclear M., Gingerich R., Finke E., Olack B., Swanson C., Giannarelli R., Navalesi R., Lacy P.E. Pulsatile insulin secretion from isolated human pancreatic islets. Diabetes 1994, 43:827-830.
346. Scharp D.W. Isolation and transplantation of islet tissue. World J. Surg. 1984, 8:143-151.
347. Orive G., Hernandez R.M., Gascón A.R., Calafiore R., Chang T.M., De Vos P., Hortelano G., Hunkeler D., Lacik I., Shapiro A.M., Pedraz J.L. Cell encapsulation: promise and progress. Nat. Med. 2003, 9:104-107.
348. Lembert N., Wesche J., Petersen P., Zschocke P., Enderle A., Planck H., Ammon H.P. Macroencapsulation of rat islets without alteration of insulin secretion kinetics. Exp. Clin. Endocrinol. Diabetes 2001, 109(2):116-119.
349. Altman J.J., Houlbert D., Callard P., McMillan P., Solomon B.A., Rosen J., Galletti P.M. Long-term plasma glucose normalization in experimental diabetic rats with macroencapsulated implants of benign human insulinomas. Diabetes Jun 1986, 35(6):625-633.
350. Isayeva I.S., Kasibhatla B.T., Rosenthal K.S., Kennedy J.P. Characterization and performance of membranes designed for macroencapsulation/implantation of pancreatic islet cells. Biomaterials Sep 2003, 24(20):3483-3491.
351. Basta G., Calafiore R. Immunoisolation of pancreatic islet grafts with no recipient's immunosuppression: actual and future perspectives. Curr. Diab. Rep. Oct 2011, 11(5):384-391.
352. Blasi P., Luca G., Mancuso F., Schoubben A., Calvitti M., Giovagnoli S., Basta G., Becchetti E., Ricci M., Calafiore R. Conformal polymer coatings for pancreatic islets transplantation. Int. J. Pharm. Jan 20 2013, 440(2):141-147.
353. Tatarkiewicz K., Garcia M., Omer A., Van Schilfgaarde R., Weir G.C., De Vos P. C-peptide responses after meal challenge in mice transplanted with microencapsulated rat islets. Diabetologia May 2001, 44(5):646-653.
354. de Vos P., Vegter D., De Haan B.J., Strubbe J.H., Bruggink J.E., Van Schilfgaarde R. Kinetics of intraperitoneally infused insulin in rats. Functional implications for the bioartificial pancreas. Diabetes Aug 1996, 45(8):1102-1107.
355. Zhi Z.L., Khan F., Pickup J.C. Multilayer nanoencapsulation: a nanomedicine technology for diabetes research and management. Diabetes Res. Clin. Pract. Dec 27 2012, (pii: S0168-8227(12)00492-5). 10.1016/j.diabres.2012.11.027.
356. Teramura Y., Iwata H. Bioartificial pancreas microencapsulation and conformal coating of islet of Langerhans. Adv. Drug Deliv. Rev. Jun 15 2010, 62(7-8):827-840.
357. Mets J.M., Wilson J.T., Cui W., Chaikof E.L. An automated process for layer-by-layer assembly of polyelectrolyte multilayer thin films on viable cell aggregates. Adv. Healthc. Mater. 2013 Feb, 2(2):266-270.
358. Gruessner A.C. 2011 update on pancreas transplantation: comprehensive trend analysis of 25,000 cases followed up over the course of twenty-four years at the International Pancreas Transplant Registry (IPTR). Rev. Diabet. Stud. 2011, 8:6-16.
359. Isla Pera P., Moncho Vasallo J., Guasch Andreu O., Ricart Brulles M.J., Torras Rabasa A. Impact of simultaneous pancreas-kidney transplantation: patients' perspectives. Patient Prefer Adherence 2012, 6:597-603.
360. Barton F.B., Rickels M.R., Alejandro R., Hering B.J., Wease S., Naziruddin B., Oberholzer J., Odorico J.S., Garfinkel M.R., Levy M., Pattou F., Berney T., Secchi A., Messinger S., Senior P.A., Maffi P., Posselt A., Stock P.G., Kaufman D.B., Luo X., Kandeel F., Cagliero E., Turgeon N.A., Witkowski P., Naji A., O'Connell P.J., Greenbaum C., Kudva Y.C., Brayman K.L., Aull M.J., Larsen C., Kay T.W., Fernandez L.A., Vantyghem M.C., Bellin M., Shapiro A.M. Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care 2012, 35:1436-1445.
361. Bellin M.D., Barton F.B., Heitman A., Harmon J.V., Kandaswamy R., Balamurugan A.N., Sutherland D.E., Alejandro R., Hering B.J. Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes. Am. J. Transplant. 2012, 12:1576-1583.
362. Thompson D.M., Begg I.S., Harris C., Ao Z., Fung M.A., Meloche R.M., Keown P., Meneilly G.S., Shapiro R.J., Ho S., Dawson K.G., Al Ghofaili K., Al Riyami L., Al Mehthel M., Kozak S.E., Tong S.O., Warnock G.L. Reduced progression of diabetic retinopathy after islet cell transplantation compared with intensive medical therapy. Transplantation 2008, 85:1400-1405.
363. Hirshberg B., Rother K.I., Digon B.J., Lee J., Gaglia J.L., Hines K., Read E.J., Chang R., Wood B.J., Harlan D.M. Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression: the National Institutes of Health experience. Diabetes Care 2003, 26:3288-3295.
364. Feng H., Shuda M., Chang Y., Moore P.S. Clonal integration of a polyomvirus in human merkel cell carcinoma. Science 2008, 319:1096-1100.
365. Chick, W.L., Sullivan, S.J., Borland, K.M., Harvey, J.M., Muller, T.E., Dunleavy, K.E., King, D.J. Jr., Doherty, E.J., Solomon, B.A., Foley, A.L. Artificial pancreatic perfusion device. United States Patent 5,002,661, March 26, 1991. W.R. Grace & Co.
366. Chick, W.L., Rupp, R.G. Artificial pancreatic perfusion device with reseedable matrix. United States Patent 5,116,493, May 26, 1992. W.R. Grace & Co.
367. Chick, W.L., Sullivan, S.J. Artificial pancreatic perfusion device with temperature sensitive matrix. United States Patent 5,116,494, May 26, 1992. W.R. Grace & Co.
368. Dionne, K.E., Emerich, D.F., Hoffman, D., Sanberg, P.R., Christenson, L., Hegre, O.D., Scharp, D.W., Lacy, P.E., Aebischer, P., Vasconcellos, A.V., Lysaght, M.J., Gentile, F.T. Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products. United States Patent 6,960,351, November 1, 2005. Brown University Research Foundation.
369. Laurance, M.E., Knaack, D., Fiore, D.M., Hegre, O.D. Glucose responsive insulin secreting.beta.-cell lines and method for producing same. United States Patent 5,534,404, July 9, 1996. CytoTherapeutics.
370. Holland, L.M., Hammang, J.P., Rudnick, S.A., Lysaght, M.J., Dionne, K.E., Method for implanting encapsulated cells in a host. United States Patent 5,550,050, August 27, 1996. CytoTherapeutics.
371. Baetge, E.E., Hammang, J.P., Gentile, F.T., Lindner, M.D., Winn, S.R., Emerich, D.F. Delivery of biologically active molecules using cells contained in biocompatible immunoisolatory capsules. United States Patent 5,639,275, June 17, 1997. CytoTherapeutics.
372. Baetge, E.E., Hammang, J.P., Gentile, F.T., Lindner, M.D., Winn, S.R., Emerich, D.F. Compositions and methods for the delivery of biologically active molecules using cells contained in biocompatible capsules. United States Patent 5,653,975, August 5, 1997. CytoTherapeutics.
373. Baetge, E.E., Hammang, J.P. Gentile, F.T., Lindner, M.D., Winn, S.R., Emerich, D.F. Compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules. United States Patent 5,676,943, October 14, 1997. CytoTherapeutics.
374. Laurance, M.E., Knaack, D. Fiore, D.M., Hegre, O.D. Glucose responsive insulin secreting.beta.-cell lines and method for producing same. United States Patent 5,773,255, June 30, 1998. CytoTherapeutics.
375. Dionne, K.E., Hegre, O.D., Flanagan, T.R., Hazlett, T.F., Doherty, E.J. Inner supported biocompatible cell capsules. United States Patent 5,773,286, June 30, 1998. CytoTherapeutics.
376. Schinstine, M., Shoichet, M.S., Gentile, F.T., Hammang, J.P., Holland, L.M., Cain, B.M., Doherty, E.J., Winn, S.R., Aebischer, P. Method for controlling the distribution of cells within a bioartificial organ using polycthylene oxide-poly (dimethylsiloxane) copolymer. United States Patent 5,776,747, July 7, 1998. CytoTherapeutics.
377. Dionne, K.E., Hegre, O.D., Flanangan, T.R., Hazlett, T.F., Doherty, E.J. Inner-supported, biocompatible cell capsules. United States Patent 5,786,216, July 28, 1998. CytoTherapeutics.
378. Schinstine, M., Shoichet, M.S., Gentile, F.T., Hammang, J.P., Holland, L.M., Cain, B.M., Doherty, E.J., Winn, S.R., Aebischer, P. Method for controlling proliferation and differentiation of cells encapsulated within bioartificial organs. United States Patent 5,795,790, August 18, 1998. CytoTherapeutics.
379. Schinstine, M., Shoichet, M.S., Gentile, F.T., Hammang, J.P., Holland, L.M., Cain, B.M., Doherty, E.J., Winn, S.R., Aebischer, P. Methods and compositions of growth control for cells encapsulated within bioartificial organs. United States Patent 5,833,979, November 10, 1998. CytoTherapeutics.
380. Gentile, F.T., Winn, S.R., Lysaght, M., Baurmeister, U., Wechs, F., Rottger, H. Bioartificial organ containing cells encapsulated in a permselective polyether suflfone membrane. United States Patent 5,837,234, November 17, 1998. CytoTherapeutics.
381. Schinstine, M., Shoichet, M.S., Gentile, F.T., Hammang, J.P., Holland, L.M., Cain, B.M., Doherty, E.J., Winn, S.R. Aebischer P. Methods and compositions of growth control for cells encapsulated within bioartificial organs. United States Patent 5,840,576, November 24, 1998. CytoTherapeutics.
382. Schinstine, M., Shoichet, M.S., Gentile, F.T., Hammang, J.P., Holland, L.M., Cain, B.M., Doherty, E.J., Winn, S.R., Aebischer, P. Controlling proliferation of cells before and after encapsulation in a bioartificial organ by gene transformation. United States Patent 5,843,431, December 1, 1998. CytoTherapeutics.
383. Schinstine, M., Shoichet, M.S., Gentile, F.T., Hammang, J.P., Holland, L.M., Cain, B.M., Doherty, E.J., Winn, S.R., Aebischer, P. Methods and compositions of growth control for cells encapsulated within bioartificial organs. United States Patent 5,853,717, December 29, 1998. CytoTherapeutics.
384. Schinstine, M., Shoichet, M.S., Gentile, F.T., Hammang, J.P., Holland, L.M., Cain, B.M. Doherty, E.J., Winn, S.R., Aebischer, P. Control of cell growth in a bioartificial organ with extracellular matrix coated microcarriers. United States Patent 5,858,747, January 12, 1999. CytoTherapeutics.
385. Hammang, J.P., Baetge, E.E., Spear, P.D., Tsiaras, W.G. Method for treating ophthalmic diseases. United States Patent 5,904,144, May 18, 1999. CytoTherapeutics.
386. Baetge, E.E., Hammang, J.P., Gentile, F.T., Lindner, M.D., Winn, S.R., Emerich, D.F. Compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules. United States Patent 5,908,623, June 1, 1999. CytoTherapeutics.
387. Schinstine, M., Shoichet, M.S., Gentile, F.T., Hammang, J.P., Holland, L.M., Cain, B.M., Doherty, E.J., Winn, S.R., Aebischer, P. Methods and compositions of growth control for cells encapsulated within bioartificial organs. United States Patent 5,935,849, August 10, 1999. CytoTherapeutics.
388. Skjak-Braek, G., Smidsrod, O., Espevik, T., Otterlei, M., Soon-Shiong, P. Cells encapsulated in alginate containing a high content of a- l- guluronic acid. United States Patent 5,459,054, October 17, 1995. Neocrin.
389. Lamberti, F. Method for manufacturing minimal volume capsules containing biological materials. United States Patent 5,827,707, October 27, 1998. Neocrin.
390. Gray, B., Baird, M.K., Lamberti, F. Isolation of cells from organ tissue using sonication. United States Patent 5,879,939, March 9, 1999. Neocrin.
391. Brauker, J.H., Hill, R.S., Martinson, L.A., Boggs, D.R., Johnson, R.C. Tissue inplant systems and methods for sustaining viable high cell densities within a host. United States Patent 5,314,471, May 24, 1994. Baxter.
392. Lee, C., Hornacek, C., Dinh, T.T. Process for purifying collagenase. United States Patent 5,332,503, July 26, 1994. Baxter.
393. Clarke, R.A., Pauley, R.G., Hill, R.S., Brauker, J.H., Sternberg, S., Boggs, D.R. Closed porous chambers for implanting tissue in a host. United States Patent 5,344,454, September 6, 1994. Baxter.
394. Lee, C.T., Hornacek, C., Dinh, T.T. Composition containing collagenase and chymopapain for hydrolyzing connective tissue to isolate cells. United States Patent 5,422,261, June 6, 1995. Baxter.
395. Lee, C.T., Hornacek, C., Dinh, T.T. Method for isolating cells from tissue with a composition containing collagenase and chymopapin. United States Patent 5,424,208, June 13, 1995. Baxter.
396. Chan, E.K.M., Pauley, R.G., Brauker, J.H., Woo, L. Laminated barriers for tissue implants. United States Patent 5,453,278, September 26, 1995. Baxter.
397. Neuenfeldt, S., Brauker, J., Clarke, R. Ported tissue implant systems and methods of using same. United States Patent 5,545,223, August 13, 1996. Baxter.
398. Neuenfeldt, S. Brauker, J., Clarke, R., Carr-Brendel, V. Method for implanting tissue in a host. United States Patent 5,549,675, August 27, 1996. Baxter.
399. Martinson, L.A., Brauker, J.H., Johnson, R.C., Loudovaris, T. Methods for enhancing vascularization of implant devices. United States Patent 5,569,462, October 29, 1996. Baxter.
400. Brauker, J.H., Hill, R.S., Martinson, L.A., Boggs, D.R., Johnson R.C. Tissue implant systems and methods for sustaining viable high cell densities within a host. United States Patent 5,593,440, January 14, 1997. Baxter.
401. Clarke, R.A., Pauley, R.G., Hill, R.S., Brauker, J.H., Sternberg, S., Boggs, D.R. Closed porous chambers for implanting tissue in a host. United States patent 5,653,756, August 5, 1997. Baxter.
402. Neuenfeldt, S., Brauker, J.H. Tissue implant systems. United States Patent 5,713,888, February 3, 1998. Baxter.
403. Neuenfeldt, S., Brauker, J., Clarke, R. Ported tissue implant system and methods of using the same. United States Patent 5,733,336, March 31, 1998. Baxter.
404. Brauker, J.H., Johnson, R.C., Martinson, L.A., Hill, R.S. Close vascularization implant material. United States Patent 5,714,330, April 21, 1998. Baxter.
405. Brauker, J.H., Johnson, R.C., Martinson, L.A., Hill, R.S. Close vascularization implant material. United States Patent 5,782,912, July 21, 1998. Baxter.
406. Brauker, J.H., Johnson, R.C., Martinson, L.A., Hill, R.S. Close vascularization implant material. United States Patent 5,800,529, September 1, 1998. Baxter.
407. Brauker, J.H., Martinson, L.A., Sternberg, S., Bellamy, D. Porous microfabricated polymer membrane structures. United States Patent 5,807,406, September 15, 1998. Baxter.
408. Brauker, J.H., Johnson, R.C., Martinson, L.A., Hill, R.S., Close vascularization implant material. Untied States Patent 5,882,354, March 16, 1999. Baxter.
409. Brauker, J.H., Johnson, R.C., Martinson, L.A., Hill, R.S. Close vascularization implant material. United States Patent 5,964,804, October 12, 1999. Baxter.
410. Pauley, R.G., McLarty, D.L., Khare, A.R., Sternberg, S., Boggs, D.R., Neuenfeldt, S., Jones, M., Brauker, J.H., Martinson, L.A. Multiple-layer, formed-in-place immunoisolation membrane structures for implantation of cells in host tissue. United States Patent 6,060,640, May 9, 2000. Baxter.
411. Brauker, J.H., Geller, R.L., Johnston, W.D., Levon, S.A., Maryanov, D.A. Implanted tumor cells for the prevention and treatment of cancer. United States Patent 6,156,305, December 5, 2000. Baxter.
412. Schlokat, U., Fischer, B., Falkner, F., Dorner, F., Eibl, J. Fusion protein comprising a furin derivative or a derivative of a furin analogue and a heterologous sequence. United States Patent 6,210,929, April 3, 2001. Baxter.
413. Schwarz, A., Byrne, G.W., Davis, T.A., Diamond, L.E., Logan, J.S. Inhibition of xenoreactive antibodies. United States Patent 6,572,867, June 3, 2003. Baxter.
414. Plaimauer, B., Schlokat, U. Furin polypeptides with improved characteristics. United States Patent 6,596,526, July 22, 2003. Baxter.
415. Brauker, J.H., Hill, R.S., Johnson, R.C., Martinson, L.A., Johnston, W.D. Angiogenic tissue implant systems and methods. United States Patent 6,773,458, August 10, 2004. Baxter.
416. D'Amour, K.A., Agulnick, A.D., Baetge, E.E. Preprimitive streak and mesendoderm cells. United States Patent 7,985,585, July 26, 2011. Viacyte.
417. Agulnick, A., D'Amour, K., Baetge, E.E. Methods for increasing definitive endoderm production. United States Patent 7,993,916, August 9, 2011. Viacyte.
418. Martinson, L., Kroon, E., D'Amour, K., Baetge, E.E. Methods of producing pancreatic hormones. United States Patent 7,993,920, August 9, 2011. Viacyte.
419. D'Amour, K.A., Bang, A., Baetge, E.E. Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production. United States Patent 8,129,182, March 6, 2012. Viacyte.
420. Dalton, S., Sheppard, A., Jones, K., Baetge, E.E., D'Amour, K.A., Agulnick, A.D. Methods for increasing definitive endoderm differentiation of pluripotent human embryonic stem cells with PI-3 kinase inhibitors. United States Patent 8,187,878. May 29, 2012. Viacyte.
421. D'Amour, K.A., Agulnick, A.D., Eliazer, S., Baetge, E.E. Methods for identifying factors for differentiating definitive endoderm. United States Patent 8,216,836, July 10, 2012. Viacyte.
422. Martinson, L., Green, C., Kroon, E., Agulnick, A., Kelly, O., Baetge, E.E. Encapsulation of pancreatic cells derived from human pluripotent stem cells. United States Patent 8,278,106, October 2, 2012. Viacyte.
423. Kelly, O., Bang, A. Methods for purifying endoderm and pancreatic endoderm cells derived from human embryonic stem cells. United States Patent 8,338,170, December 25, 2012. Viacyte.
424. Antanavich, R.D., Dorian, R. Retrievable bioartificial implants having dimensions allowing rapid diffusion of oxygen and rapid biological response to physiological change. United States Patent 5,855,613, January 5, 1999. Islet Sheet Medical.
425. Antanavich, R.D., Dorian, R. Retrievable bioartificial implants having dimensions allowing rapid diffusion of oxygen and rapid biological response to physiological change, processes for their manufacture, and methods for their use. United States Patent 6,165,225, December 26, 2000. Islet Sheet Medical.
426. Antanavich, R.D., Dorian, R. Retreivable bioartifical implants having dimensnsions allowing rapid diffusion of oxygen and rapid biological response to physiological change, processes for their manufacture, and methods of their use. United States Patent 6,372,244, April 16, 2002. Islet Sheet Medical.
427. Butler, M.D., Davidson, D.F., Mish, S.L., Moore III, J.W. Implantable containment apparatus for a therapeutical device and method for loading and reloading the device therein. United States Patent 5,843,069, December 1, 1998. Gore Hybrid Technologies.
428. Butler, M.D., Davidson, D.F., Mish, S.L., Moore III, J.W. Implantable containment apparatus for a therapeutical device. United States Patent 6,471,687, October 29, 2002. Gore Hybrid Technologies.
429. Rotem, A., Evron, Y., Vardi, P., Block, K. Implantable device. United States Patent 8,012,500, September 6, 2011. Beta-O2.
430. Goosen, M.F.A., O'Shea, G.M., Sun, A.M.F. Microencapsulation of living tissue and cells. United States Patent 4,689,293, August 25, 1987. Connaught Labs.
431. Lim, F. Sustained Release. United States Patent 4,690,682, September 1, 1987. Damon Biotech.
432. D'Amour, K.A., Agulnick, A.D., Baetge, E.E. Definitive endoderm. United States Patent 7,510,876. March 31, 2009. Cythera.
433. Martinson, L., Kroon, E., D'Amour, K. Methods of producing pancreatic hormones. United States Patent 7,534,608, May 19, 2009. Cythera.
434. D'Amour, K.A., Agulnick, A.D., Eliazer, S., Baetge E.E. Methods for identifying factors for differentiating definitive endoderm. United States Patent 7,541,185, June 2, 2009. Cythera.
435. Kelly, O., Baetge, E.E., Carpenter, M. Expansion of definitive endoderm cells. United States Patent 7,625,753, December 1, 2009. Cythera.
436. Agulnick, A., D'Amour, K., Baetge, E.E. Methods for increasing definitive endoderm production. United States Patent 7,695,963, April 13, 2010. Cythera.
437. Martinson, L., Kroon, E., D'Amour, K., Baetge, E.E. Methods of producing pancreatic hormones. United States Patent 7,695,965, April 13, 2010. Cythera.
438. D'Amour, K.A., Agulnick, A.D., Baetge, E.E. Definitive Endoderm. United States Patent 7,704,738, April 27, 2010. Cythera.
439. Hubbell, J.A., Pathak, C.P., Sawhney, A.S., Desai, N.P., Hill-West, J.L., Hossainy, S.F.A. Gels for encapsulation of biological materials. United States Patent 5,573,934, November 12, 1996. Board of Regents, The University of Texas System.
440. Hubbell, J.A., Pathak, C.P., Sawhney, A.S., Desai, N.P., Hossainy, S.F.A. Gels for encapsulation of biological materials. United States Patent 6,258,870, July 10, 2001. Board of Regents, The University of Texas Systems.
441. Gary, B., Baird, M.K., Lamberti, F. Isolation of cells from organ tissue using sonication. United States Patent 6,489,164, December 3, 2002. Novocell.
442. Hubbell, J.A., Pathak, C.P., Sawhney, A.S., Desai, N.P., Hossainy, S.F.A. Gels for encapsulation of biological materials. United States Patent 6,911,227, June 28, 2005. Novocell.
443. Scharp, D., Latta, P., Yue, C., Yu, X., Hubbell, J.A. Implantation of encapsulated biological materials for treating diseases. United States Patent 7,427,415, Sept 23, 2008. Novocell.
444. Lanza, R.P., Kuhtreiber, W.M., Chick, W.L. Methods of use of uncoated gel particles. United States Patent 5,651,980, July 29, 1997. Biohybrid Technologies.
445. Lanza, R.P., Chick, W.L. Non-steroidal anti-inflammatory agents inhibition of fibrotic response to an implanted device. United States Patent 5,891,477, April 6, 1999. Biohybrid Technologies.
446. Lanza, R.P., Kuhtreiber, W.M., Chick, W.L. Methods of use of uncoated gel particles. United States Patent 5,912,005, June 15, 1999. Biohybrid Technologies.
447. Lanza, R.P., Kuhtreiber, W.M., Chick, W.L. Microcapsules and composite microreactors for immunoisolation of cells. United States Patent 6,126,936, October 3, 2000. Biohybrid Technologies.
448. Lanza, R.P., Ecker, D.M., Ringeling, J., Marsh, J.P., Chick, W. Devices containing cells or tissue and an agent that inhibits damage by a host cell molecule. United States Patent 6,287,558, September 11, 2001. Biohybrid Technologies.c.
449. Lanza, R.P., Chick, W. Devices for cloaking transplanted cells. United States Patent 6,368,612, April 9, 2002. Biohybrid Technologies.
450. Soon-Shiong, P., Desai, N.P., Heintz, R.E. Cytoprotective, biocompatible, retrievable macrocapsule containment systems for biologically active materials. United States Patent 5,545,423, August 13, 1996. VivoRx.
451. Desai, N.P., Soon-Shiong, P., Sandford, P.A., Heintz, R.E. Process for encapsulating biologics using crosslinkable biocompatible encapsulation system. United States Patent 5,550,178, August 27, 1996. VivoRx.
452. Desai, N.P., Soon-Shiong, P., Sandford, P.A., Heintz, R.E. Graft copolymers of polycationic species and water-soluble polymers, and use therefor. United States Patent 5,578,442, November 26, 1996. VivoRx.
453. Soon-Shiong, P., Desai, N.P., Sandford, P.A., Heintz, R.A., Sojomihardjo, S. Gel compositions prepared from crosslinkable polysaccharides, polycations and/or lipids and uses therefor. United States Patent 5,700,848, December 23, 1997. VivoRx.
454. Soon-Shiong, P., DeSai, N.P., Sandford, P.A., Heintz, R.A., Sojomihardjo, S. Microcapsules prepared from crosslinkable polysaccharides, polycations and/or lipids and use therefor. United States Patent 5,705,270, January 6, 1998. VivoRx.
455. Soon-Shiong, P. Physiological cell separation and method of separating cells using same. United States Patent 5,739,033, April 14, 1998. VivoRx.
456. Soon-Shiong, P., Desai, N.P., Heintz, R.E. Cytoprotective, biocompatible, retrievable microcapsule containment systems for biologically active materials. United States Patent 5,759,578, June 2, 1998. VivoRx.
457. Soon-Shiong, P., Heintz, R.E., Skjak-Braek, G. Microencapsulation of cells. United States Patent 5,762,959, June 9, 1998. VivoRx.
458. Soon-Shiong, P., Desai, N.P., Heintz, R.E. Method for making cytoprotective, biocompatible, retrievable microcapsule containment systems. United States Patent 5,788,988, August 4, 1998. VivoRx.
459. Desai, N.P., Soon-Shiong, P., Sandford, P.A., Heintz, R.E. Graft copolymer of polycationic species and water-soluble polymers, and uses therefor. United States Patent 5,834,556, November 10, 1998. VivoRx.
460. Soon-Shiong, P., Desai, N.P., Sandford, P.A., Heintz, R.E., Sojomihardjo, S. Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release. United States Patent 5,837,747. November 17, 1998. VivoRx.
461. Soon-Shiong, P., Desai, N.P., Sandford, P.A., Heintz, R.E., Sojomihardjo, S. Macrocapsules prepared from crosslinkable polysaccharides, polycations and/or lipids and uses therefore. United States Patent 5,846,530, December 8, 1998. VivoRx.
462. Soon-Shiong, P., Desai, N.P., Heintz, R.E. Method of treating patients with diabetes. United States Patent 5,879,709, March 9, 1999. VivoRx.
463. Soon-Shiong, P., Desai, N., Ron, N., Sojomihardjo S., A., Heintz, R., Curcio, F. Cytoprotective biocompatible containment systems for biologically active materials and methods of, making same. United States Patent 6,495,161, December 17, 2002. VivoRx.
464. Tsang, W., Zheng, T., Huang, C.J. Culturing pancreatic stem cells having a specified, intermediate stage of development. United States Patent 6,759,039, July 6, 2004. Am Cyte.
465. Tsang, W., Zheng, T., Wang, Y. In situ maturation of cultured pancreatic stem cells having a specified, intermediate stage of development. United States Patent 7,101,546, September 5, 2006. Am Cyte.
466. Dorian, R.E., Cochrum, K.C. Microcapsule generating system containing an air knife and method of encapsulating. United States Patent 5,521,079, May 28, 1996. Regents of the University of California.
467. Dorian, R.E., Cochrum, K.C. Microcapsule generating system containing an air knife and method of encapsulating. United States Patent 5,521,079, May 28, 1996. Regents of the University of California ((((((COPY)))))).
468. Cochrum, K.C., Dorian, R.E., Jemtrud, S.A. Multiple layer alginate coatings of biological tissue for transplantation. United States Patent 5,578,314, November 26, 1996. Regents of the University of California.
469. Dorian, R.E., Cochrum, K.C. Cells or tissue coated with non-fibrogenic alginate less than 200.mu.m thick. United States Patent 5,656,468, August 12, 1997. Regents of the University of California.
470. Mjalli, A.M.M., Rothlein, R., Tian, Y.E., Webster, J.C., Benjamin, E.J. RAGE fusion proteins, formulation, and methods of use thereof. United States Patent 7,981,424, July 19, 2011. TransTech.
471. Mjalli, A.M.M., Rothlein, R., Tian, Y.E., Webster, J.C. Nucleic acid molecules encoding rage fusion proteins. United States Patent 8,344,120, January 1, 2013. TransTech (Metabolex).
472. Dorian, R.E., Cochrum, K.C. Non-fibrogenic high mannuronate alginate coated transplants, processes for their manufacture, and methods for their use. United States Patent 5,693,514, December 2, 1997. Metabolex.
473. Enevold, K.C. Method of solution overcoating with gelling polymer. United States Patent 5,738,876, April 14, 1998. Metabolex.
474. Enevold, K.C. Encapsulation compositions, and methods. United States Patent 5,916,790, June 29, 1999. Metabolex.
475. Enevold, K.C. Encapsulation compositions and methods. United States Patent 6,020,200, February 1, 2000. Metabolex.
476. Usala, A. Bioartificial endocrine device. United States Patent 5,614,205, March 25, 1997. Encelle.
477. Usala, A. Electrochemical biosensors. United States Patent 5,776,324, July 7, 1998. Encelle.
478. Usala, A. Bioartificial devices and cellular matrices therefor. United States Patent 5,824,331, October 20, 1998. Encelle.
479. Usala, A. Bioartificial devices and cellular matrices therefor. United States Patent 5,830,492, November 3, 1998. Encelle.
480. Usala, A. Bioartificial devices and cellular matrices therefor. United States Patent 5,834,005, November 10, 1998. Encelle.
481. Usala, A. Methods for increasing vascularization and promoting wound healing. United States Patent 6,713,079, March 30 2004. Encelle.
482. Usala, A., Klann, K.C. Medium and matrix for long-term proliferation of cells. United States Patent 6,730,315, May 4, 2004. Encelle.
483. Mullon, C.J.P., Dunleavy, K.E. Artificial pancreatic perfusion device. United States Patent 5,741,334, April 21, 1998. Circe Biomedical.
484. Stegemann, J.P., O'Neil, J.J., Mullon, C.J.P. Artificial pancreas. United States Patent 6,023,009, February 8, 2000. Circe Biomedical.
485. Dunleavy, K.E., Perlman, T.J., Gagnon, K.A., Mullon C.J.P. Encapsulation device. United States Patent 6,042,909, March 28, 2000. Circe Biomedical.
486. Lim, F. Encapsulation of biological material. United States Patent 4,352,883, October 5, 1982. Damon Corporation.
487. Chang, T.M. Nonthrombogenic microcapsules. United States Patent 3,522,346, July 29, 1970. McGill University, Montreal Canada.
488. Chang, T.M. Blood compatible microencapsulated detoxicants and method for making. United States Patent 3,725,113, April 3, 1973. McGill University, Montreal Canada.
489. Zimmermann, U. Preparing small microcapsules containing high concentration of cells or tissue. United States Patent 6,465,226, October 15, 2002. (No assignee).